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Abstract 
In this work, the effects of fullerene-based nanoparticles (fullerene and two of its derivatives) 
on the structure and functioning of proteins were investigated. An approach combining two 
computational methods — molecular docking and molecular dynamics simulations — was used. 
The studies were based on, and complement experiments on the effects on nanoparticles on 
proteins. 
  
To make a better prospective, ﬁrst, the properties of nanoparticle clusters in water were 
studied. The nature and stability of the clusters were found to depend on the surface properties 
of the nanoparticle. Nanoparticles with hydrophobic surfaces made strong and stable clusters, 
whereas hydrophilic nanoparticles made loose associations whose structure changed over 
time. In addition, the effects of nanoparticles on the secondary structure of small peptides were 
studied. For some peptides, a small increase in the alpha-helix content was observed in the 
presence of nanoparticles.  
  
For protein-nanoparticle interactions, the inhibition of an enzyme protein, namely taq DNA 
polymerase, by fullerene derivatives was studied. Based on our studies, we predicted that the 
inhibition was caused by tertiary structural changes of the protein induced by the 
nanoparticles. Point mutation studies which could be used to examine our predictions 
were also proposed. In another study, the inhibition of tubulin self-assembly into microtubules 
by fullerene species was investigated. Simulation studies indicated that binding of 
nanoparticles to certain locations on tubulin was responsible for the inhibition. These 
binding sites are important for self-assembly as they are located in areas that make contact 
with the neighboring tubulins in microtubules. Finally, interactions of FUL and FUOH 
nanoparticles with ubiquitin was studied. Two more prominent binding sites, including one 
near the C-terminal tail was observed, and the biological implications of the binding are 
discussed. 
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Statement of contribution
This Dissertation focuses on the interaction between proteins and fullerene-based
nanoparticles. Two articles based on the work described in Sections 5.3 and 5.4 have
been published:
[I] “Mechanism of Taq DNA Polymerase Inhibition by Fullerene Derivatives: In-
sight from Computer Simulations”, P. Nedumpully Govindan, L. Monticelli, E.
Salonen, J. Chem. Phys. B, 116, 10676 (2012).
[II] “In Vitro Polymerization of Microtubules with a fullerene Derivative”, T. A.
Ratnikova, P. Nedumpully Govindan, E. Salonen, P. C. Ke, ACS Nano, 5, 6306
(2011).
Publication [I] is computational in nature and is based on the work described in 5.3.
The author carried out setting up and running the simulations, analyzing the results
and writing up the first draft of the article. Publication [II] includes both computa-
tional and experimental studies. The computational part is based on the work de-
scribed in Section 5.4. The author performed setting up and running the simulation,
and analyzing the results. He also wrote the first draft of the part concerning simula-
tions, which was then revised by other authors of the manuscript.
A third article based on the results described in Section 5.5 is under preparation
and will be published in a peer reviewed journal. Further work is underway for the
effects of fullerene nanoparticles on secondary structures described in Section 5.2.
The results of this study will also be published in peer reviewed journal. The author
has independently carried out almost all parts of this work, including conceiving
and planning the research, setting up and running the simulations and analyzing the
results.
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1. Overview
Since the invention of the computer in the 20th century, computational methods have
opened a new paradigm in scientific research. In molecular biology, nowadays they
have opened a new window to the length and time scales which are hardly attainable
by experimental methods. This Dissertation deals with computational approaches
to study biological systems. More specifically, two computational methodologies
— molecular dynamics and molecular docking — are used to study the interactions
between proteins and fullerene-based nanoparticles.
Any scientific process (see Fig. 1.1) begins by posing a question about a system.
The systems of interest are often too complex, so to achieve a better understand-
ing, simple model systems of the real system are made. A model can be theoretical,
computational or even experimental. An experimental model system is one using
which an understanding of the important properties of a more complex system can
be gained. For example, single component (or multicomponent) phospholipid mem-
branes are often used to understand the properties of the much more complex cell
membranes. Computational/theoretical models are the representation of the real sys-
tem and sets of rules [1]. Simulations, which this work employs, are used to measure
quantities using computational models. It complements the theoretical predictions
based on model systems and experimental observations of the real or model systems.
Comparisons are made between experimental observations, theoretical predictions
and computational results, and conclusions are drawn.
As for the systems related to this Dissertation, the scientific question asked, on a big
picture, is “what are the effects of nanoparticles on biological systems?”. Since bi-
ological systems are too complex, and proteins do most of the important “work” in
7
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Figure 1.1. A flowchart of the scientific methodology. The work related to this Dissertation is based on
computer simulations of model systems.
them, the question is simplified and reframed to “what are the effects of nanoparticles
on proteins and their functioning?”. As will be discussed in Chapter 3, experiments
have shown that nanoparticles indeed affect the structure and functioning of proteins.
Now, the next question is “how and why nanoparticles affect proteins?”. This Disser-
tation attempts to answer this question in a few selected cases. In doing so, whenever
it is possible, comparisons are made with experimental results.
This Dissertation is organized as follows. In Chapter 2, a general account of proteins,
their structure and their functioning are given. The three proteins which are studied
in this Dissertation, namely taq DNA polymerase, tubulin and ubiquitin, are also
described in detail. In Chapter 3, the properties of fullerene-based nanoparticles are
discussed. The studies on their effect on biological systems are described briefly.
And finally, the experimental results which motivated this work are detailed.
The computational methods used in this work are described in Chapter 4. In Sec-
tions 5.3, 5.4 and 5.5 the results on the interaction of nanoparticles with taq DNA
polymerase, tubulin and ubiquitin are discussed, respectively. The cluster properties
of nanoparticles are described in Section 5.1 and their effects on the stabilities of
α-helical structures in 5.2. Finally, a brief summary and views on future research
directions are given in Chapter 6.
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2. Background on proteins
2.1 Introduction
The diversity of life on earth is astonishing. A virus, which is the simplest form of
life1, may consist of only genetic material (DNA or RNA) and a protein coat. But
some organisms have trillions of cells with distinct organs performing specific func-
tions (human body, for instance, is a colony of more than 1013 cells [2]). Despite
this diversity, the fundamental mechanisms by which life progresses in different or-
ganisms are strikingly similar. Cells are the structural and functional building blocks
of higher forms of life. The basic biological functions of cells are similar in all
species. Cells (and some intercellular organelles) are separated and protected from
the surroundings by membranes. The genetic information is stored in nucleic acids.
Proteins are the “workforce” which perform almost all the cellular functions.
2.2 Proteins
Proteins constitute most of the dry mass of cells [2]. They are called the building
blocks of cells because they are responsible for almost all cellular functions [2]. For
example, enzyme proteins catalyze chemical reactions necessary for cell function-
ing. Ion channels and ion pumps are membrane proteins which selectively transport
small molecules in and out of cells, thus acting like gates. Proteins such as tubulin
help cells to maintain their size and shape by giving mechanical strength. They also
1There is also a different viewpoint in which viruses are not life forms but organic structures
interacting with life.
9
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Figure 2.1. A cartoon of the animal cell [3].
play a role in cellular locomotion and cell division. Motor proteins such as kinesin
transport cellular organelles and macromolecules. Messenger proteins are involved
in transmitting messages between cells. Proteins also function as toxins, antibodies
and capsids.
Proteins are co-polymers of their basic subunits called amino acids [2]. Typical pro-
teins consist of 50 to 2000 amino acids [2]. Neighboring amino acids in a protein are
covalently connected to each other via peptide bonds (Fig. 2.2), hence protein chains
are also known as polypeptides [2]. Depending on its sequence of amino acids, a
protein assumes its unique three dimensional structure [2]. The function of a pro-
tein depends on its shape. This is because proteins need to bind specifically to other
molecules for their functioning, and this requires a certain surface conformation de-
pending on the binding molecule. Since the shape of a protein is determined by its
amino acid sequence, the functioning of a protein also depends on its amino acid
sequence.
Amino acids are small molecules which have an amine group and a carboxylic acid
group connected to a central alpha carbon atom (Cα ) [4]. A peptide bond is formed
by the chemical reaction between the amine group of an amino acid with the car-
boxylic group of its neighbor (see Fig. 2.2). The amino and carboxylic groups and
10
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Figure 2.2. Amino acids in a protein chain are connected via peptide bonds. Amino acids have amine
and carboxylic groups and a side chain (marked R). These three groups are attached to the
Cα atom of amino acid [5].
the Cα atom which repeat along a polypeptide chain form the peptide backbone or
the main chain [4]. Another important moiety of the amino acids which does not take
part in the peptide bond formation is the side chain (marked R in Fig. 2.2). Twenty
different types of side chains are found in naturally occurring proteins, and hence 20
different types of amino acids [4]. Since the amino acids differ only in the side chains,
differences in their nature and properties depend only on the side chains. Some of
the side chains are charged whereas some are charge-neutral [4]. Neutral amino acids
can be polar or non-polar. One end of the polypeptide chain has a free amine group
and the other end has a free carboxyl group. They are called the N-terminus and the
C-terminus, respectively. By convention, the amino acids (also called residues) in the
polypeptide chain are numbered starting from the N-terminus.
The peptide bond is planar and hence the conformations which a protein chain can
assume are greatly limited [4]. The non-covalent interactions between atoms are usu-
ally 30-300 times weaker than covalent bonds such as peptide bonds [2]. However,
collectively, the non-bonded interactions are significant and they further limit the
conformations proteins can assume. Most proteins, under suitable conditions, fold
into a single free energy minimum conformation called the native state [4]. In the
native structure, the non-polar residues are usually buried inside the protein and the
polar residues are distributed on the surface due to the hydrophobic effect. Other
non-covalent interactions which play important role in protein folding are hydrogen
11
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Figure 2.3. Twenty different amino acids are found in naturally occurring proteins [4].
bonds and electrostatic and van der Waals interactions [2].
The native structure can be disturbed by changes in the environment. Proteins lose
their native structure or they denature by changes in temperature, pH or solvent type
[2]. Upon denaturation, proteins lose their functionality, but they usually return to
their native states and regain activity if the favorable conditions are restored. Inter-
actions with other molecules can also change the native structure of a protein, which
may also affect their functioning. This is a very important aspect for the complex
molecular mechanisms by which cells function. Functioning of many proteins is
“switched off” or “switched on” by the binding of other molecules. The binding
molecules can be small molecules, nucleic acids or proteins themselves. Many drug
molecules, for instance, work by binding to a target protein and altering its function-
ing [6]. As will be discussed later, in this Dissertation the effect of fullerene-based
nanoparticles on the structure and functioning of proteins is studied.
Large proteins may have domains which fold into their own native structures more
or less independently of the rest of the protein [2]. Domains can also function inde-
pendently. For example, taq DNA polymerase, which we will discuss in this Disser-
tation has three domains that can function independently. Different organisms have
12
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structurally similar proteins to perform a particular task. These proteins may have
different amino acid sequences (two proteins may need only about 30% similarity in
their amino acid sequences to fold into similar structures). However, if a particular
amino acid is seen to be conserved across different species, it is usually an indication
for the importance of that amino acid in the functioning of the protein.
2.2.1 Four levels of protein structure
Earlier in this section, we learned that the three-dimensional structure of a protein is
very important for its functioning. For ease, the structures of proteins are described at
four levels [4] (Fig. 2.4). The amino acid sequence of a protein is called its primary
structure. The primary structure helps to distinguish proteins with similar structures,
and also to identify proteins with similar sequences. The second level is the local
secondary structure which is discussed in detail in the next section. A full three
dimensional structure of a peptide chain is called its tertiary structure. The tertiary
structure describes the relative positions of all atoms in a peptide chain. If a protein
consists of more than one peptide chain (e.g., tubulin dimer), the relative positions
and orientations of individual chains describe the quaternary structure.
2.2.2 Secondary structure
Although folded structures of different proteins are different, some local patterns are
universal. These are called the secondary structures [4]. Secondary structures are
formed by the interaction between amino acids close to each other in sequence. The
interaction responsible for secondary structures is hydrogen bonding formed between
amine and carboxylic groups of the peptide backbone. These bonds do not involve
any side chains and hence the universality of secondary structures. However, the side
chains of some residues can have an influence on the secondary structures. The two
most commonly found secondary structures are α-helices and β-sheets.
An α-helix is formed when a polypeptide backbone twists around an axis, forming
a spring-like structure (Fig.2.5). In principle, both left- and right-handed helices are
possible, but left-handed helices are unstable due to steric hindrance. In an α-helix,
the hydrogen bonds are formed between the carboxyl group of residue i with the
13
Background on proteins
Figure 2.4. The protein structure can be described at four levels as schematically shown here [3].
Figure 2.5. The two most common secondary structures of protein: β-sheets (parallel and antiparallel)
and α-helix [7].
14
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amine group of residue i+ 4 [8]. A protein is translated by about 3.6 amino acids
per turn of an α-helical structure (with a pitch of 0.54 nm) [9]. Some residues, due
to their intrinsic nature, are helix-friendly, meaning that they favor helix formation.
Alanine, leucine and methionine are examples for such residues [10]. Some other
residues such as cysteine, aspartic acid and glycine tend to destabilize α-helices [10].
Two less-commonly found helical structures are the 310-helix and pi-helix [8]. In
a 310-helix, the hydrogen bond is formed between residues i and i+ 3, making the
structure more compact than the α-helix. In a pi-helix, the hydrogen bond formation
is between residues i and i+5.
β-sheets are formed when hydrogen bonds are formed between two or more peptide
strands, called β-strands (Fig. 2.5) [8]. β-strands are typically 3-10 amino acids long.
The adjacent strands can be oriented either in the same or in the opposite direction.
Thus β-sheets can be parallel, antiparallel or mixed. Residues such as phenylalanine,
valine and isoleucine are favorable residues for β-sheet formation [8].
Two other commonly found secondary structures of proteins are turns (also called
hairpin bends or β-turns) and loops. Both of them connect secondary structures such
as α-helices and β-sheets. The difference between them is that turns are small motifs
(typically 3–5 residues) with hydrogen bonds between them, giving them a well-
defined structure, whereas loops are longer motifs without a well-defined structure
[8]. Turns are seen in regions with a sharp change in orientation such as between
antiparallel β-strands. Loops are usually flexible, rich in hydrophilic residues, and
are seen on the surface of proteins.
The secondary structure can be determined by looking at the hydrogen bond patterns.
An alternative method is by measuring the dihedral angles of the peptide backbone.
As mentioned before, the peptide bond is planar and hence non-rotatable, whereas
Cα -C and Cα -N bonds of amino acids are rotatable. However, for residues involved
in secondary structure formation, rotation about these bonds are limited due to steric
hindrance between atoms [4]. Hence, the corresponding dihedral angles can have
only certain values. By measuring these dihedral angles, the secondary structure
formed can be determined. The dihedral angles around Cα -C and Cα -N bonds are
traditionally represented by ψ and φ , respectively.
15
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A {ψ , φ} plot for the residues of a protein is called the Ramachandran plot [4]. For
residues involved in right-handed and left-handed α-helical structures, the favorable
{ψ , φ} values are about {-60, -50} and {+60, +60}, respectively [8]. For parallel and
anti-parallel β-sheets, the values are {-120, +115} and {-140, +135}, respectively [8].
In experiments, the secondary structure content of a protein is usually determined
using circular dichroism (CD) spectroscopy [11]. It is based on the difference in the
absorption of left-polarized and right-polarized light by regular structures. α-helical,
β-sheet and random coil structures show their characteristic spectrum with far-UV
light. Thus by looking at the CD spectrum, it is possible to predict the α-helical and
β-sheet contents of a protein [11].
So far in this chapter we have discussed some of the basic aspects about the structure
and functioning of proteins. In the following sections we shall discuss three proteins
in more detail. They are an enzyme protein called taq DNA polymerase, tubulin
which is the building block of microtubules, and ubiquitin which is involved in many
cellular processes. The functioning of these proteins in the presence of fullerene-
based nanoparticles is the theme of this Dissertation.
2.3 Taq DNA Polymerase
Taq DNA polymerase belongs to a DNA polymerase family of proteins. The proteins
in this family are enzymes involved in the duplication and repair of DNA [12]. The
function of DNA polymerases is to catalyze the addition of nucleotides to synthesize
new DNA strands [13]. A DNA polymerase uses a template DNA strand to deter-
mine the nucleotide sequence, and makes a new DNA strand [2]. The short strand to
which nucleotides are added one by one, is called the primer DNA.
Taq DNA polymerase (taq pol in short) is a DNA repair enzyme which adds nu-
cleotides to DNA in the thermophilic bacterium thermus aquaticus. A salient feature
of taq pol is its thermostability [14] — it has the ability to function at very high
temperatures due to the thermophilic nature of the bacterium. It is one of the most
important enzymes in molecular biology because of its usage in polymerase chain
reaction. Polymerase chain reaction (PCR) uses polymerase enzymes to copy DNA
in vitro (details in section 2.3.3). PCR requires repeated heating and cooling of the
16
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Figure 2.6. Klentaq fragment of taq DNA polymerase consists of exonuclease and polymerase do-
mains. The polymerase domain has fingers, palm and thumb subdomains [13]. The O, H
and I helices of the polymerase domain are highlighted in green.
reaction solution. Because of its thermal stability, taq pol is highly preferred in PCR
over other polymerase enzymes.
Taq pol has three domains, a 5’ nuclease domain, an inactive 3’-5’ exonuclease do-
main and a polymerase domain [15] (Fig. 2.6 shows the exonuclease and polymerase
domains, which together form the Klentaq fragment). The polymerization reaction
is catalyzed by the polymerase domain. This domain looks like a right hand and
has three subdomains called thumb, fingers and palm [13] (see Fig. 2.6). Three car-
boxylic residues in the palm subdomain (Asp 610, Asp 785 and Glu 786) form the
active site for the catalysis [15].
An important property of any polymerase protein is its fidelity. Fidelity of a poly-
merase is the ability to copy a DNA strand without making any mistakes in the nu-
cleotide sequence. Taq pol makes one mistake in about 9000 nucleotide additions
and is one of the polymerases with low fidelity [16]. This is considered a drawback
of taq pol and is caused by the inactivity of its exonuclease domain (whose function
is to correct errors that the polymerase domain makes). However, taq pol is widely
used to amplify small fragments of DNA in laboratories. The fidelity of taq pol can
be improved by cleaving the the 5’ nuclease domain, leaving the Klentaq fragment
17
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Figure 2.7. The DNA replication fork. In the duplication process, DNA is unwound, strands are sepa-
rated and each strand is copied by proteins [3].
of the protein [17]. In one of the studies described in this Dissertation, the Klentaq
fragment is used for simulations although the names taq DNA polymerase and taq
pol are also interchangeably used.
2.3.1 Copying of DNA in cells
DNA consists of two strands which form the famous double helix structure. The
sequence of nucleotides in two strands are complementary to each other (due to
Watson-Crick base pairing) and anti-parallel. During DNA duplication (see Fig. 2.7),
the DNA is unwound by a protein called topoisomerase, and the two strands are sep-
arated by another protein called helicase. Two polymerase proteins then bind the two
single stranded DNAs, use them as templates, and synthesize two new DNA strands.
These two newly synthesized strands complement their templates, so in the end two
exact copies of the original double stranded DNA are made.
2.3.2 Functioning of taq DNA polymerase
For catalyzing the polymerization reaction, taq pol binds to a single-stranded DNA
with a bound primer and aligns it properly. During this process, a large conforma-
tional change occurs in the thumb subdomain [12]. Provided that a right type of a
deoxy-nucleoside triphosphate (dNTP) binds to the protein at the O-helix of the fin-
gers subdomain, the helix undergoes an orientational change [12]. By changing the
orientation of the O-helix, taq pol makes a transition from an “open” to a “closed”
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state. This causes the dNTP to get closer to the DNA and orient in the appropriate
way [12]. The polymerization reaction takes place in this closed state [18]. Three
acidic residues (Asp785, Glu786 and Asp610) in the palm subdomain form the ac-
tive site, and catalyze the addition of the nucleoside to the DNA [12]. The fingers
subdomain then repositions back to the open state, and the nucleoside addition pro-
cess is repeated until either the DNA copying is completed or until the DNA unbinds
from the protein.
2.3.3 Polymerase Chain Reaction
In laboratories, small fragments of DNA are amplified using PCR. The method was
introduced by Kary Mullis in 1983 and uses polymerase enzyme to duplicate DNA
[19]. Up to millions of copies of a DNA sample can be produced by repeating the
duplication cycle. A PCR cycle involves at least three steps [20]:
(i) Denaturation. The reaction solution containing the DNA sample, short primer
DNAs, dNTPs and polymerase is heated above 90 °C. During this step the double
stranded DNA is separated into two single strands.
(ii) Annealing. The temperature is lowered to 50–60 °C in this step. Short primer
DNAs bind the single stranded DNAs. Taq pol binds the template-primer DNA com-
plex.
(iii) Elongation. Nucleotides are added to the primer during this step. The polymerase
enzyme catalyzes the nucleotide addition. The temperature depends on the optimal
temperature of the polymerase. For taq pol the temperature is typically 75–80 °C
Many proteins denature if heated to above 90 °C. However, taq DNA polymerase is
thermophilic and does not denature or lose activity at high temperature and hence it
is routinely used in PCR.
2.4 Tubulin and microtubule assembly
As mentioned earlier in this Chapter, some proteins are involved in giving mechani-
cal strength to cells and cellular organelles. The cytoskeleton is an important cellular
component whose main purpose is to give mechanical strength [2]. It is also nec-
essary for many cellular processes such as inter-cellular transport, cell movement
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Figure 2.8. Tubulin dimer is made of α- and β-tubulins. GTP (left) and GDP (right) molecules are
bound to the N- and E-sites, respectively. The atomic coordinates of the structure were
obtained from Protein Data Bank (PDB ID: 1TUB [24]), and the figure was created using
the molecular graphics software VMD [25].
and cell division [21]. The eukaryotic cytoskeleton has three constituents: microfil-
aments, intermediate filaments and microtubules. Of these, microtubules are cylin-
drical structures with a diameter of about 25 nm [22]. They are highly dynamic
structures and grow up to many micrometers in length [23].
The basic building blocks of microtubules are tubulins [2]. Each tubulin, in turn,
is a dimer of two structurally similar globular proteins called α- and β-tubulins [26],
bonded non-covalently (Fig. 2.8). Both α- and β-tubulins have one guanosine triphos-
phate (GTP) binding site each. The GTP binding site of α-tubulin is at the α–β
interface of the dimer. The GTP molecule bound at this site is stable and non-
exchangeable, hence the site is called the non-exchangeable site (or N-site) [2]. The
GTP bound to β-tubulin, on the other hand, can be hydrolyzed to guanosine diphos-
phate (GDP). The resulting GDP molecule at this site can be exchanged with a GTP,
hence the binding site is called the exchangeable site (E-site) [2].
Polymers formed by the non-covalent addition of tubulin dimers are called the protofil-
aments [2]. A hollow tube-like structure or a microtubule is formed by the bundling
of 13 protofilaments with lateral interactions [2]. Since dimers can be added only
head-to-tail to the protofilaments, the two ends grow differently. The growing end
will have only β-tubulins exposed while the other end has only α-tubulins exposed.
The two ends are called the + end and - end, respectively. The microtubules are thus
said to have a polarity.
20
Background on proteins
Figure 2.9. Microtubule assembly and disassembly [27]. GTP-bound tubulins (shown in green in so-
lution, and red in microtubule) are assembled into microtubules, which can then hydrolyze
the bound GTP molecule to a GDP molecule and a phosphate. The GDP-bound tubulins
(blue) fall off microtubule in the absence of a GTP-bound tubulin cap (red).
Another important feature of the microtubule is its dynamic instability [28]. It is the
phenomenon because of which microtubules switch between growth and shrinkage
phases. To understand dynamic instability, one has to know how microtubule assem-
bly takes place. As explained earlier, the N-site of a tubulin always binds a GTP
molecule whereas the E-site can bind either a GTP or a GDP molecule. Depend-
ing on which one of them binds to the E-site, a tubulin is called to be either in a
GDP-bound or GTP-bound state. GTP-bound tubulins have straight contact between
their monomers, whereas GDP-bound tubulins are structurally different with a kink
between the monomers [29]. To be able to take part in the microtubule assembly, a
tubulin has to be in the GTP-bound state [2], a GDP-bound tubulin cannot take part
in the microtubule assembly [30].
The GTP-bound tubulins in a microtubule can hydrolyze GTP to GDP and a free
phosphate [31]. This process is stochastic in nature. The resulting GDP-bound tubu-
lin has a tendency to disassemble from the microtubule. However, whether the GDP-
bound tubulin falls off or not depends on its location. If it is located at the + end of
the microtubule, it falls off immediately. However, if it is not located at the + end, it
is interlocked between other tubulins (which may be GTP- or GDP-bound) [32]. One
has to keep in mind that free GTP-bound tubulins, if available above certain concen-
tration, are constantly added to the + end. This means most of the time the + end
grows slowly, leaving behind tubulins in GTP- or GDP-bound states. If tubulins at
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the + end hydrolyze their GTP to GDP, they and all the GDP-bound tubulins behind
them fall off [31]. This is called a shrinkage phase or catastrophe. This catastro-
phe continues until a GTP-bound tubulin is reached. In a catastrophe the length of a
microtubule decreases rapidly.
2.5 Ubiquitin
Ubiquitin is a small protein consisting of 76 amino acids [4]. It is found ubiquitously
(hence the name) in all eukaryotic cells, either as free or attached to other proteins.
It is highly conserved [4], meaning that its amino acid sequence remains almost un-
changed across families of organisms. For example, 73 out of the 76 amino acids in
human and Arabidopsis thaliana (a plant) ubiquitins are the same.
The most important function of ubiquitin is related to protein degradation [2]. Degra-
dation of unwanted proteins is important for the cellular functioning, and is carried
out by the ubiquitin-proteasome system. The role of ubiquitin in protein degradation
was discovered in 1970 and the discovery was awarded the Nobel prize in Chemistry
in 2004 [33]. Chemical attachment of ubiquitin to target proteins serves like a la-
bel for their degradation [34]. Proteins labeled for degradation are broken down to
smaller peptide chains (a few amino acids long) by a protein complex called protea-
some [34], and the peptides are reused for the synthesis of new proteins.
The chemical attachment of ubiquitin to a protein requires three associated proteins
[4]. The first one, called the ubiquitin-activating enzyme or E1, activates ubiquitin
as its name suggests [4]. The activation happens by the attachment of terminal car-
boxylate group of ubiquitin to E1 by a thioester bond. In the second step, ubiquitin
is transferred to a ubiquitin-conjugating enzyme E2 [4]. Finally, the attachment of
ubiquitin to the actual target protein is catalyzed by a ubiquitin-ligase enzyme E3 [4].
E1, E2 and E3 are not specific proteins; a number of different proteins serve as E1,
E2 or E3. Attachment of a single ubiquitin to a target protein does not necessarily
mark it for degradation, but attachment of a chain of four or more ubiquitins does.
The degrading proteasome complex has a catalyzing subunit and a regulatory subunit
which recognizes polyubiquitin chains.
Protein degradation is not the only cellular process ubiquitin is involved in. Ubiqui-
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Figure 2.10. Cartoon representation of a ubiquitin molecule. In polyubiquitin chains, the C-terminal
residue of one ubiquitin molecule is attached to Lys48 or Lys63 residues of the subsequent
ubiquitin [35].
Figure 2.11. Degradation of a target protein by the ubiquitin-proteasome system. The attachment of
ubiquitin to a target protein requires three enzymes (E1, E2 and E3). The ubiquitinated
protein is broken down by proteasome [33].
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tin also takes part in protein trafficking, DNA repair, the assembly of protein signal-
ing complexes, immune function and the activation or inactivation of enzymes [36].
Whether or not proteins are marked for destruction by ubiquitination depends on how
the individual ubiquitins are connected to each other in the chain [2]. If the linking is
through Lys48 of one ubiquitin and the C-terminal glycine of the consecutive ubiqui-
tin, the target protein is degraded by proteasome [36]. Chains linked through Lys63
and C-terminal glycine are involved in protein trafficking or signaling [36].
Given the role of ubiquitin in many cellular processes, it is not surprising that any
failure of ubiquitin-associated processes would cause diseases and disorders. These
include cancer, neurodegenerative disorders and dysfunctioning of the immune sys-
tem. For example, human papilloma virus (HPV) causes the activation of a specific
E3 enzyme. This, in turn, leads to the destruction of proteins that control DNA re-
pair, which can result in cancer [4]. In fact, 5.2% of all cancers are caused by HPV
infection [37].
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3. Fullerene nanoparticles and their
biological effects
3.1 Nanoparticles
A nanoparticle, by definition, is a particle whose size is smaller than about 100 nm at
least in one dimension [38]. Physical and chemical properties of nano-sized materials
are different from their macroscopic counterparts. The properties of nanoparticles are
not only different from those of their bulk counterparts but also depend on the size,
shape, surface properties of the nanoparticle [39]. For example, the color of gold and
silver nanoparticles changes as their size is changed [40]. Similarly, reaction rates
of particles increase as the size decreases because of the increase in total surface
area. Solubility changes dramatically with changes in the surface chemistry [41].
The toxicity of fullerene-based nanoparticles changes over 7 orders of magnitude by
changing the surface derivatization [42]. Since in this fashion it is possible to alter
the properties of nanoparticles according to the need, they are promising for many
applications [43, 44].
In the early 1990s new and efficient methods were developed to synthesize and ma-
nipulate nanoparticles. Since then nanoparticles have been the subject of research in
physics, chemistry, materials science and even biomedicine [45–47]. Nowadays it is
possible to tune the size, composition and surface properties of certain nanoparticles.
As a result, their application and usage increased tremendously, both in industrial
products and for research purposes. There are more than 1300 nanoparticle-based
products already in the market, and this number is likely to increase [48]. Nanoparti-
cles are thus nowadays produced in large quantities and their entry to the environment
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is inevitable. Concerns about their environmental and biological effects are growing
as more is understood about their fate in the environment [39, 49].
Some of the nanoparticles released to the environment are able to reach inside organ-
isms through inhalation, ingestion or through contact with the skin [50]. Fine carbon
nanoparticles are reported to get deposited in lungs through inhalation [51]. Inside
organisms they are able to cross various biological barriers. They are even able to
cross the blood-brain barrier — one of the most difficult biological protective barrier
to cross — and to reach the brain [52]. Nanoparticles such as fullerenes are able
to partition into membranes surrounding the cells. They have also been reported to
reach inside the cells and to inter-cellular organelles [53]. Inside cells (and also on
the surface of cells) they can interact with a vast number of biomolecules, affect their
functioning and hence the functioning of the entire cellular machinery.
The effect of nanoparticles on cellular machinery can be boon or bane and cannot
be predicted a priori; studies have reported both their beneficial and harmful effects.
Nanoparticles show antibacterial [54–58] and antiviral [59–61] activities, reduce the
growth of tumor cells [62] and act as antioxidants [63, 64], and function as drug
carriers [61], to name a few beneficial effects. Adverse effects include acting as
cytotoxic substances [42, 65, 66], inducing cell contractions [67], affecting the func-
tioning of proteins and nucleic acids (see section 3.3 for more details) and inducing
oxidative stress to cells [68]. Although concerns of harmful effects of nanoparticles
on biological systems are premature, it is important to address them for the healthy
development of nanotechnology [39]. In order to minimize risks and maximize the
benefits of nanoparticles, more research at the fundamental level is needed [39]. De-
velopment of mathematical and computational models has been identified as an area
of priority that needs to be addressed in order to develop safe nano-medicines [69].
As discussed in the previous Chapter, proteins play a very important role in cellu-
lar machinery by complex interactions between themselves and with other types of
molecules. If one or more of these interactions are altered by nanoparticles, the cel-
lular functioning can be disrupted. Thus to understand how xenobiotic substances
affect cellular functioning, knowledge of their effect on important proteins (and other
molecules) is necessary.
The nanoparticles whose biological effects are studied here are the fullerene C60, also
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Figure 3.1. Fullerene and its derivatives studied here. Pristine fullerene C60 (left), fullerol C60(OH)20
(middle) and fullerene trimalonic acid C63(COO)6 (right).
known as the buckminsterfullerene, and two of its derivatives, fullerol C60(OH)20 and
fullerene trimalonic acid C63(COO)6 (Fig. 3.1). In the following section, properties
of these three nanoparticles are discussed and in Section 3.3, previous findings on
their effects on biosystems are described. In Section 3.4, the motivation for this work
is discussed. The aim of this work is to understand the molecular mechanisms by
which these nanoparticles affect the functioning of proteins.
3.2 Fullerene and its derivatives
Fullerene is the third allotrope of carbon discovered, after diamond and graphite.
Fullerenes are caged structures formed of pentagons and hexagons of carbon atoms.
Unlike diamond and graphite, which can be “infinite”, fullerenes are finite; the num-
ber of carbon atoms in a fullerene is fixed. Thermodynamically, larger planar struc-
tures are stable but if the number of atoms is limited, the surface curves and forms
a caged fullerene. The atoms are sp2 hybridized and each one is bonded to three
other carbon atoms. Fullerenes consist of many hexagons and pentagons. The bonds
shared between two hexagons (6:6 bonds) have a double bond nature, and are shorter
than the other bonds (6:5 bonds, shared between one hexagon and one pentagon).
The term fullerene represents many molecules with spherical or ellipsoidal shape.
Carbon nanotubes and graphite are closely related to fullerenes [70]. Fullerene was
discovered in 1985 and nanotubes in 1991. Fullerenes occur naturally [71] and are
found even in outer space. C60 fullerene (Fig. 3.1), which is made of 60 carbon
atoms, is probably the most commonly used fullerene for research purposes, C70
fullerene with 70 carbon atoms being the second one. C60 fullerene is spherical with
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a diameter of about 0.7 nm [72, 73].
Solubility
One of the key issues with the use of fullerenes is that they are virtually insoluble
in water due to their hydrophobicity. The solubility of C60 fullerene is less than
10−9 mg/L in water [74], but it is soluble in many other solvents such as hydrocar-
bons [73, 75]. To solvate fullerene in water, different techniques can be used [41]
which include (a) encapsulation in special carriers, (b) use of co-solvents to suspend
fullerenes, (c) chemical modification of fullerene surface and (d) suspending with the
help of sonication. C60 fullerenes are effectively dissolved in water by encapsu-
lating them in compounds such as γ-cyclodextrin and calixerene [76] or in micelles
[77, 78] and liposomes [77]. Fullerenes are also dissolved in detergents or coated
with molecules to improve solubility. Polyvinylpyrrolidone (PVP) [79], gallic acid
[67, 80] and natural organic matter (NOM1) [81] are examples of such compounds.
Among these, NOM is particularly interesting because of its presence in the environ-
ment. When nanoparticles are released to the environment, they come in contact with
NOM and stable complexes may be formed [82, 83].
Without encapsulating fullerenes, their solubility can be increased dramatically by
attaching hydrophilic groups to their surface. Polyhydroxylated fullerenes (called
fullerols or fullerenols, see Fig. 3.1), for instance, are very soluble in water even
though their structure is not very well defined [41]. Lamparth and Hirsch synthe-
sized a highly soluble malonic acid fullerene derivative (fullerene trimalonic acid,
see Fig. 3.1) with a well defined three-dimensional structure [84]. Solubility can also
be enhanced by attaching water-soluble polymers [62], amino acids [85] and many
other hydrophilic moieties to the fullerene cage.
Cluster properties
Dry C60 fullerene lump (fullerite) forms the simple cubic structure at low tempera-
tures and the face-centered cubic (fcc) structure with a lattice constant of 1.417 nm
above 249 K [86]. In water, due to their hydrophobicity, C60 molecules cluster and
1NOM is a collection of broken down matter from dead organisms. It consists of proteins,
lipids, sugars and many chemicals.
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form colloids called nano-C60. The sizes of nano-C60 vary from tens to a few hun-
dreds of nm [56, 68]. In vacuum, fullerenes form clusters. Clusters of 13 and 55
fullerenes are observed to form particularly stable icosahedral structures [87].
Production
To produce fullerenes, graphite rods are evaporated by passing a large electric cur-
rent through them. The resulting fullerene soot contains a mixture of C60, C70, nan-
otubes and many other nanoparticles. The fullerenes are then extracted and separated
[73]. In order to synthesize fullerols, multiple hydroxyl groups are introduced on the
fullerene cage by treating it with sulfuric acid [88], sodium hydroxide in the presence
of a catalyst (tetrabutylammonium hydroxide) [89] or a mixture of hydrogen perox-
ide and sodium hydroxide [90]. Fullerene malonic acid derivatives are synthesized by
first producing an adduct of fullerene with diethyl bromomalnate, which is converted
to the malonic derivative by hydrogenolysis [84, 91].
3.3 Effect of fullerene nanoparticles on biosystems
Effects of fullerene nanoparticles on biosystems have been extensively studied. Both
beneficial and harmful effects have been reported. In the following, some of these
studies are discussed.
Cell/Organism level
C70 fullerenes and C60(OH)20 fullerols induce cell lysis [92] and cell contraction
[67], reducing the volume of the cells by about 50%. Fullerene derivatives were re-
ported to cause toxicity to human cells [42]. The extent of toxicity depends on the
surface functionalization of fullerene [42]. Fullerene derivatives accumulated pref-
erentially in tumor cells compared to healthy cells and showed anti-tumor activity
with no apparent side effects [62, 93]. An anti-fullerene antibody was produced in
mice [94]. Antiapoptosis activities of fullerene trimalonic acid derivative were re-
ported by Huang et al. [95]. Inhaled carbon nanoparticles were able to cross the
blood-brain barrier to reach brain in rats [52]. In fish fullerene nanoparticles in-
duced oxidative stress in brain [68]. The mortal effects of C60 cluster on two aquatic
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species depended on the procedure with which the fullerenes were dissolved in water.
Nano-C60 dissolved using tetrahydrofuran was mortal whereas water-stirred nanoC60
showed much less toxicity [96].
Membranes
Fullerenes are reported to be able to cross cell membranes and reach inside cells
[53]. Fullerenes cause damage to membranes by inducing lipid peroxidation [97].
The damage is reported to be caused by reactive oxygen species (ROS) [98]. Lipid
composition, phase transition temperature and fluidity of cell membranes are altered
by nano-C60 [99]. MD simulation studies of fullerene and fullerol with lipid mem-
branes showed that fullerenes translocate into the membrane and stay at about 1 nm
from the center [100], while the preferred location of fullerol is near the head group,
about 2.3 nm from the center. Coarse grained MD simulations of fullerenes showed
that fullerenes prefer to aggregate while in water (forming nano-C60), and it is favor-
able for the aggregates to partition into the membrane than staying in water [101].
Further, the aggregates tend to disaggregate once they reach the hydrophobic tail re-
gion of the membrane. Similar insertion of small carbon nanotubes into membranes
has also been observed in MD simulations [102].
Nucleic acids
In the presence of light, fullerene and its derivatives are capable of cleaving DNA
molecules [103–106]. In 1994 Nakamura and coworkers reported guanine-specific
cleavage of DNA by a fullerene derivative [103]. The cleavage was believed to be
induced by reactive oxygen species, which include singlet oxygen, superoxide radi-
cal ion and hydroxyl ion, produced by fullerene [105]. Fullerenes are also capable of
distorting the DNA structure. MD simulations by Zhao and others showed that C60
binds and deforms A-form double stranded DNA and single stranded DNA, but does
not change the overall shape of B-form double stranded DNA [107]. The binding
energies were in the range from -113 to -176 kJ/mol. Further, simulations of C60
derivatives with single stranded DNA showed that the interaction energy and inter-
action pattern depends on the surface modification of the nanoparticle [108]. Strong
interaction with the DNA backbone was seen in simulations with fullerol [109].
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Proteins and enzymes
Fullerene forms aggregates with lysozyme [110] and fullerol reduces the ability of
lysozyme to dissolve bacterial cell wall by up to 50% at 1:5 molar ratio (lysozyme:fullerol)
[111]. The secondary structure of the protein was also altered by fullerol: the α-
helical content was reduced from 41.8% to 29.1% at 1:1 molar ratio [111]. Fullerene
molecules form water soluble complexes with bovine serum albumin (BSA) without
any significant change in the secondary structure of the protein [112]. Similarly com-
plex formation of human serum albumin (HSA) with the malonic acid derivative of
fullerene has also been also reported [113].
The effect of 8 fullerene derivatives (including one dimalonic acid derivative) on the
functioning of human immunodeficiency virus reverse transcripatase (HIV-RT) and
hepatitis C RNA-dependent RNA polymerase (HVC-RP) were studied by Mashino et
al. [114]. They found that nanoparticles inhibit the functioning of the enzymes. The
IC50 value2 for dimalonic acid derivative was found to be 1.2 μM and 3.2 μM for HIV-
RT and HVC-RP, respectively. A substrate-dependent inhibition of the activities of
rodent liver Glutathione-S-transferase (GST) by polyvinylpyrrolidone-solvated fullerene
was reported by Iwata et al. [115]. Fullerenes also inhibited human GST and mod-
erately inhibited glutathione peroxidase and glutathione reductase [115]. Meng et al.
reported that fullerol and TMA derivatives inhibit Moloney Murine Leukemia virus
reverse transcriptase [116].
Based on computational studies, Friedman and coworkers predicted that fullerene
derivatives fit the hydrophobic cavity of HIV1-Protease (HIV1-P) and hence can be
an inhibitor [60]. A fullerene derivative indeed reduced the HIV1 infection of blood
cells with an EC50 value 7 μM, with no toxic effect on uninfected cells [60]. Tuck-
erman and coworkers used MD simulations to find that a fullerene core in the hy-
drophobic core of HIV-P affects the opening of protease flaps [117]. The presence
of fullerene causes a barrier for flap opening and the location of the barrier depends
on the protonation state of catalytic Asp residue oxygens. They further discovered
that the cavity undergoes structural changes for accommodating fullerene core more
effectively and consequently more water molecules are excluded from the region.
2IC50 is the concentration of an inhibitor at which 50% of the maximal activity is lost. EC50 is
the plasma concentration of the inhibitor at which 50% of the activity is lost in in vivo trials.
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Enzyme Nanoparticle Notes Ref
MuLV RT FUOH, TMA IC50= 89 µM and 39 µM [116]
HIV RT DMA, 7 others IC50= 1.2 µM (DMA) [114]
HIV P Many C60 derivatives Ki= ~µM to ~100 nM [60, 119]
Lysozyme FUOH 50 % activity at 1:5 lys:FUOH [111]
HVC RP DMA, 7 others IC50= 3.2 µM (DMA) [114]
Taq pol TMA, FUOH IC50= 6.0 µM (TMA) [120, 121]
GST FUL Substrate-dependent inhibition [115]
Hind III TMA IC50= 16.3 µM [122]
EcoR I TMA IC50= 6.0 µM [122]
Table 3.1. Enzymes inhibited by fullerene and its derivatives. DMA = Dimalonic acid C60 derivative.
The effect of fullerene on bacterial potassium channels (KcsA and MthK) and voltage
gated potassium channel (Kv1.2) were studied by Kraszewski et al. using computa-
tional methods [118]. They found that fullerene does not bind or block the selectivity
filter region of the channel, but binds to the hydrophobic residues of the extra-cellular
loops. If placed in the intracellular region, fullerene binds to the internal cavity en-
trance and causes a conformational change to a helix which would lead to a change
in ion conduction pathway [118].
3.4 Motivation for this work
The studies described in this Dissertation are motivated by many experiments, espe-
cially those conducted in Prof. Pu-Chun Ke’s research group in Clemson University,
USA. These experiments deal with the effect of fullerene-based nanoparticles on the
functioning of proteins.
Effects on polymerase chain reaction
Amplification of a heat shock transcription factor (HSTF) gene by polymerase chain
reaction was studied in the presence of fullerol [109]. In these experiments, as the
concentration of fullerol was increased from 0.2×10−4 mM to 1.0×10−4 mM, the
amount of amplified double stranded DNA was reduced and no double stranded DNA
was observed at concentrations higher than 1.6×10−4 mM. The hydrodynamic diam-
eter was measured using dynamic light scattering and the values obtained for protein
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  Figure 3.2. Real time PCR efficiency at different fullerol concentrations [109].
and fullerol were 10.8 (±1.9) nm and 1.0 (±0.3) nm, respectively, whereas the hy-
drodynamic diameter of the mixture was 21.9 (±10.9) nm. The reaction mixture with
4.0× 10−4 mM fullerol showed the highest UV absorbance. Since double stranded
DNA absorbs about 20% less than ssDNA and up to 40% less than dNTPs of the
same quantity, the higher absorbance at 4.0×10−4 mM fullerol further supports the
PCR inhibition.
The inhibition could be a result of the interaction of fullerols with the enzyme, single
stranded DNA or with dNTPs in the solution. At the highest fullerol concentration of
4.0×10−4 mM, the fullerol to dNTP ratio was 1:500. Thus, most of the dNTPs were
free and it was unlikely that the inhibition was caused by fullerol-dNTP binding. The
amount of taq polymerase present in the reaction solution was only given in enzyme
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units (U)3, so the exact concentration of the protein was not known. But when the
amount of taq polymerase was increased from 1 U to 4 U, the amplification was
partially restored.
In another study Meng et al. studied the effect of fullerol and trimalonic acid deriva-
tive on the polymerization of β-actin cDNA [121]. As the concentration of nanopar-
ticles was increased from 0.005 mM to 1.0 mM, the PCR products decreased. The
PCR was completely inhibited (no product was visible) at concentrations above 0.01
mM and 0.005 mM for fullerol and trimalonic derivative, respectively. To understand
which interaction causes the inhibition, the concentrations of the template DNA and
enzyme were changed. As amount of template DNA was increased by a factor of
four, little change in the product was seen in the absence or presence of fullerol. On
the other hand, when the amount of taq pol was increased from 3.8 U to 15.2 U, the
inhibition was reversed. At 0.01 mM fullerol concentration, the product reappeared
at enzyme concentration of 7.6 U, and for the same amount of trimalonic derivative,
11.4 U of enzyme was needed to recover the reaction. Thus the authors concluded
that the cause of inhibition was the interaction between the nanoparticles and the
enzyme [121]. Further, trimalonic derivative was found to have stronger inhibition
activity compared to fullerol.
From these studies, it was concluded that fullerol and trimalonic derivative are ca-
pable of inhibiting the polymerization activity of taq DNA polymerase. Since no
change in the reaction was observed as the template DNA was increased, the inhibi-
tion is not likely to be competitive. That is, it is unlikely that the nanoparticles inhibit
by binding only to the DNA binding site.
Effects on microtubule self assembly
The effect of fullerol on the polymerization of tubulins was studied by Ratnikova et
al. [120]. In control experiments without any fullerols, tubulin dimers self-assembled
to form microtubules. The synthesized microtubules had a bimodal distribution with
peaks at 5 and 20 μm (see Fig. 3.3). When fullerols were added to the reaction mix-
ture, the microtubule self-assembly was inhibited. As the concentration of fullerols
3One enzyme unit is the amount of enzyme that catalyzes its substrate at a rate 1 μmole/min
under specified conditions.
34
Fullerene nanoparticles and their biological effects
Figure 3.3. Effect of fullerol on microtubule self-assembly. Microtubule length distribution (top), num-
ber of microtubules (middle) and secondary structure content at different concentrations of
fullerol [120].
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increased from 1 mg/L to 30 mg/L (1 mg/L = 5.45 μM), the distribution became a
single-peak one centered at 3 μm. This meant that the self-assembly of tubulins into
microtubules was greatly affected in the presence of fullerols.
The effect of fullerol on the secondary structure of tubulin was studied by measuring
the circular dichroism (CD) spectrum of the samples (Fig. 3.3). The CD spectrum
was altered by the presence of fullerol, suggesting conformational change of the pro-
tein. As the fullerol concentration was increased, the number of α-helical structures
was decreased and the number of β-sheet structures increased (Fig. 3.3). The total
number of helical and sheet structures was decreased by 6.9%.
Protein-nanoparticle corona and association of fullerene nanoparticles with
ubiquitin
When nanoparticles enter inside an organism, they encounter a huge number of
biomolecules, especially proteins. Human serum, for instance, has at least 375 dis-
tinct proteins [123]. As a result, soon after their entry, large nanoparticles or large
clusters of smaller nanoparticles are coated with one or more layers of proteins, form-
ing a structure known as “protein corona” [124]. Since cells “see” only the protein
layers, and not nanoparticles, the fate of the nanoparticles in living organism is de-
termined by the proteins which cover them. The size, curvature, hydrophobicity and
chemical properties of the nanoparticle determine which proteins get adsorbed on to
them [124]. The composition of the corona changes over time, but the total amount
of proteins remains the same.
Ubiquitin is a very common protein found almost in all tissues and also in blood.
In the context of nanoparticle-protein corona, the association between fullerol and
ubiquitin was studied [125]. Fullerol suspensions with size distributions peaking
at 1.5±0.2 nm and 5.0±0.7 nm were mixed with ubiquitin. At 1:1 ubiquitin:fullerol
(U:F) molar ratio, the hydrodynamic size of the mixture was measured as 6.0±0.8 nm
and 9.7±1.3 nm. At lower (U:F ratio 5:1) and higher (U:F ratio 1:5) concentrations
of fullerol, the hydrodynamic sizes were 6.3±1.0 nm and 7.5±0.8 nm, respectively.
The zeta potentials4 of the protein, fullerol and the mixture were also measured for
4Zeta potential is an indicator of the stability of colloidal particles or macromolecules against
aggregation. When charged particles or macromolecules are placed in a liquid, they are
covered by a layer of immobile ions, and a second layer of mobile ions. Zeta potential is
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Figure 3.4. The hydrodynamic sizes of fullerol, ubiquitin and their complexes at different molar ratios.
different U:F ratios. For fullerol without ubiquitin, the zeta potential was large and
negative at -58.4±6.5 mV and for ubiquitin, it was close to zero (0.8±3.6). For the
mixture, the zeta potentials were -12.6±9.1 mV, -13.5±16.2 mV and -21.9±6.3 mV,
respectively, for U:F ratios 5:1, 1:1 and 1:5. Thus, ubiquitin is more stable against
aggregation in the presence of fullerols.
The binding constant of fullerol on ubiquitin was estimated at 4.6×104 M−1. Using
fluorescence quenching measurement, the binding site was located near the tyrosine
residue. In the presence of fullerol nanoparticles, a small decrease in the α-helical
and an increase in β-sheet contents were also observed using circular dichroism mea-
surements. These measurements suggest association between fullerol and ubiquitin.
Effects on secondary structure of proteins
In protein folding, the favorable free energy contributions arise from interactions
such as hydrophobic interactions, hydrogen bonds and van der Waals forces. These
are countered by the entropic contribution which is unfavorable for the folded state.
Since the energy balance between these two contributions is marginal for many pro-
teins, the interaction with nanoparticles could induce structural changes. In many
works, the effect of nanoparticles on the secondary structure has been studied. With
fullerene derivatives, a decrease in α-helical content and an increase in β-sheet struc-
the electrostatic potential at the surface of the inner layer (or potential at radius of shear)
with respect to a point in the bulk. Particles with large zeta potentials (absolute value) are, in
general, more stable against aggregation.
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tures was reported in many studies [111, 120, 126]. This trend is general and is seen
for interaction of proteins with many other nanoparticles [127–129]. There have also
been some studies in which fullerene derivatives showed no effect on the secondary
structure of proteins [112]. The effects of nanoparticles have a curvature dependence:
particles with low curvature (large size) cause more changes to the secondary struc-
ture compared to particles with high curvature (small size) [130]. Since preserving
structure is vital for the functioning of proteins, functioning of protein is altered or
even lost when nanoparticles induce structural changes.
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4. Computational methods
Traditionally, theory and experiment are considered as the two branches of scientific
research. Computational science is relatively a new branch of science even though
it has been in existence for more than five decades. Today, it can be considered as
the third branch of science, complementing the other two branches. The growth of
the scope of computational science is caused by many developments [8]. First, the
available computational power has exponentially increased as described by Moore’s
law1. Second, fast and efficient computational methods and algorithms have been
developed or are being developed. For computational biophysicists, there is one more
useful development: Due to the improvements of experimental techniques, structures
of a large number of molecules are being resolved. Consequently, “a new enthusiasm
is stirring in the molecular biophysics community” [8].
Physics-based computational methods use both quantum mechanical and classical
approaches. Quantum mechanics-based computational methods are useful in study-
ing phenomena involving chemical reactions, protein-ligand interactions and photo-
induced reactions, to name a few. A classical approach suffices to describe many
other phenomena. In these phenomena, quantum mechanical processes do not play
an important role and hence classical approximation is possible. Self-assembly of
lipid membranes, protein folding and interaction of proteins with small molecules
and with other proteins (but not in all cases) are examples of such phenomena. The
quantum to classical approximation is discussed in more detail in section 4.1.1. There
are also hybrid methods (QM/MM) which treat the most interesting part of the sys-
tem (e.g. enzyme reaction site) quantum mechanically and other parts classically
1Moore’s law states that the number of transistors that can be fabricated on chips doubles
approximately every two year.
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[131, 132]. The advantage of such an approach is that it increases the speed of calcu-
lation without losing the accuracy.
In this Dissertation a computational approach is used to study the interaction of pro-
teins with fullerene-based nanoparticles. The two computational methods used are
molecular dynamics simulations and molecular docking (or simply, docking). Both
of these methods treat atoms and molecules classically, but their methodologies are
different and they serve different purposes.
4.1 Molecular Dynamics
In the molecular dynamics (MD) approach [1, 133], atoms are considered as point
masses which follow classical equations of motion. The interactions between atoms
are approximated by simple functional forms, and the positions and velocities of
atoms are updated by numerical integration. The resulting trajectories, with the help
of statistical physics, are used to calculate thermodynamic properties. MD is also
useful to “see” molecular movements or conformational changes, which are often
difficult or impossible to observe in experiments.
The MD methodology is used in a wide variety of research problems, and it is proba-
bly the most commonly used computational method in molecular biology. It is used to
study all major classes of molecules in biology — lipids (membranes), proteins, car-
bohydrates and nucleic acids. The first MD simulation was the simulation of a hard
sphere system performed in 1957 [134]. The first biomacromolecular simulation had
to wait another two decades till 1977 when McCammon et al. carried out a 9.2 ps
long simulation of bovine pancreatic trypsin inhibitor [135]. Today, millisecond-long
macromolecular simulations are achievable [136].
The rationale behind the classical approximation and the equations of motion are
described in the next two sections. The potential energy function is discussed in
Section 4.1.3, and the selection of parameters in 4.1.4. Numerical algorithms used to
integrate the equations of motion and other practical issues are discussed in section
4.1.5. Finally, in Section 4.1.6, some of the challenges faced by the MD community
and the reasons why MD is still usable are discussed.
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4.1.1 From quantum to classical
In principle, the behavior of any non-relativistic physical system can be described by
solving the Schrödinger wave equation,
Hˆψn = Enψn (4.1)
where Hˆ is the Hamiltonian operator, ψn are the eigenstates, and En the correspond-
ing eigenvalues. However, the wave equation can analytically be solved only for
very simple systems such as the hydrogen atom. Solutions are thus based on many
approximations and often calculated numerically [133].
The first approximation one makes is the so-called Born–Oppenheimer approxima-
tion, named after Max Born and Robert Oppenheimer who proposed it in 1927 [1].
It relies on the fact that the mass of electrons in an atom (or molecule) is much
smaller than the mass of its nucleus, and hence the nucleus is fixed on the timescale
of electron movement. The electron wave function depends only on the nuclear po-
sition (and not on momentum) and thus the electron wave function can be decoupled
from the nuclear wave function. Solving the electron wave functions, one gets the
so-called Born-Oppenheimer energy surface [8]. The nuclear wave function is then
solved using the ground state electronic energy surface as a potential.
Although it is in principle possible to find numerical solutions to the Schrödinger
equation for systems of interest, in practice for large systems such as proteins, even
numerical solutions are cumbersome. Luckily, for studying many phenomena a com-
plete quantum mechanical treatment is not necessary. In molecular mechanics (MM),
the (average) atomic forces arising from inter-atomic interactions are represented by
simple analytical potential energy functions. Both the functional forms of the poten-
tials and the values of their parameters are required to completely describe an MM
force field. The parameters in MM force fields are optimized against experimental
data and/or quantum calculations [137].
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4.1.2 Equations of motion
The basic concept of MD is very simple: the atoms behave classically and follow
Hamilton’s equations of motion
∂H(p,q)
∂pi
= q˙i (4.2)
∂H(p,q)
∂qi
=−p˙i, (4.3)
where the Hamiltonian of the system, H(p,q), is a function of generalized coordi-
nates q and generalized momenta p,
H(p,q) =∑
i
p2i
2mi
+V (q). (4.4)
The solutions are found successively in small steps of ∆t using a finite difference ap-
proach. For solving, we should know the potential energy function V (q) as a function
of atomic coordinates and have initial positions and velocities of atoms.
4.1.3 Force field functional form
Force fields are descriptions of the potential energies of molecules as a function of
their atomic coordinates [8]. The name comes from the fact that the forces acting on
atoms depend on the gradient of the potential energy. The interactions between atoms
are modeled by mathematical equations and appropriate constants for these equations
are determined.
There are some conditions, though not rigorous, that force fields are expected to sat-
isfy [8]. First, the force field terms have to be additive. That is, the effective energy
of a molecule can be written as a sum of physical terms, such as those describing
bonds, angles, electrostatic interactions etc. The terms should be simple to make
the computation easy. But, at the same time, they have to represent the interactions
satisfactorily. So there is usually a trade-off between accuracy and computational
expense. The force field terms ideally have to be transferable between different
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molecules, meaning the same parameters should be able to be used for closely re-
lated molecules. Force fields should also perform under a variety of environments
and conditions. For instance, they should perform over a range of temperature and
pressure and under different solvent conditions.
The interactions between atoms can be divided into non-bonded and bonded inter-
actions. The non-bonded interactions include the dispersion interaction, repulsion at
very close distances arising from Pauli exclusion principle, and electrostatic interac-
tions. The first two terms are typically treated together using the 12-6 Lennard-Jones
(LJ) interaction function [133],
VLJ =∑
i, j
4εi j
((
σi j
ri j
)12
−
(
σi j
ri j
)6)
(4.5)
where i and j are atom indices and ri j is the distance between them. σ is the colli-
sion diameter (distance at which the interaction energy is zero) and ε is the potential
energy well depth. These two parameters are defined for each atom type and com-
bination rules are used for calculating the interaction between a pair of atoms. For
example, in some force fields, the ε value for a pair is obtained via geometric mean,
εi j =
√εiε j, and the σ value via the arithmetic mean σi j = (σi +σ j)/2. In some
other force fields, a geometric mean is used for both σ and ε . Mixing of parame-
ters from different force fields is not recommended if the force fields follow different
combining rules [138].
In Eq. (4.5) the sixth-power term represents the dispersion interaction which arises
from fluctuating dipole-induced dipole interactions. It has a sixth-power inverse rela-
tionship with the distance between atoms [9]. The Pauli repulsion is related to wave
function overlap, and can be effectively fitted against exponential functions of the
distance between atoms [133]. However, for computational efficiency, it is usually
replaced with a 12th power term which can be easily calculated by squaring the dis-
persion term. This approximation works for most of systems, but for some systems,
such as hydrocarbons, the 12th power term is too steep [133]. The Buckingham po-
tential uses an exponential term for the repulsive interaction and a sixth-power term
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for the dispersion interaction [133],
VBH = Ae−Bri j − Cr6i j
, (4.6)
where A, B and C are constants. At very small distances, the Buckingham potential
is attractive and special care needs to be taken to avoid unrealistic atomic contacts
[133].
The electrostatic interaction is represented by standard Coulomb’s potential,
Vq =∑
i, j
qiq j
4piε0ri j
. (4.7)
where qi and q j are the partial charges on atoms i and j, and ε0 is the permittivity of
free space. In molecules, the electrons involved in chemical bonds oscillate between
bonded atoms. Thus, the effective charges of atoms (except fully ionized ones) are not
integral multiples of e, the elementary charge unit (and hence the charges are called
“partial charges”). To accurately represent the electrostatic nature of molecules, ad-
ditional electrostatic interaction sites may need to be defined [133]. This is to ensure
that higher order electrostatic moments are reproduced along with the lowest ones.
The partial charge of an atom is not an experimentally measurable quantity. Hence
the values are first obtained and then adjusted with other parameters (such as LJ pa-
rameters), such that the chosen thermodynamic quantities are reproduced.
In Eqns. (4.5)–(4.7), the summations are typically carried out over all inter-molecular
atom pairs and those intra-molecular pairs which are separated by at least three bonds.
For atoms separated by one or two bonds, the bonded terms are thought to represent
the net interactions, so non-bonded terms are not necessary [138]. For those separated
by three bonds, the normal LJ interaction may be too strong to distort the molecule
[139], so it is scaled down by a factor in most force fields [137, 138]. The OPLS and
AMBER force fields use a scaling factor of 0.5, but in the CHARMM force field the
scaling factor is 1 (no scaling).
The bonded interaction function includes terms to model chemical bonds, bond an-
gles and dihedral terms. These three terms describe energy costs for bond stretching,
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Figure 4.1. The bonded terms of molecular mechanics force fields.
angle stretching and rotation about bonds, respectively. The bonds and angles are
usually represented by harmonic functions, dihedral terms using trigonometric func-
tions with appropriate multiplicity (multiplicity is the number of minima in the dihe-
dral angle potential as the bond is rotated through 360°). Thus the bonded potential
function usually has four terms:
Vbonded = Vbonds +Vangles +Vdihedrals +Vimproper. (4.8)
Each term in the above equation can be expanded as follows:
Vbonds = ∑
bonds
1
2
kbi j
(
ri j− r0i j
)2
, (4.9)
where ri j is the distance between chemically bonded atoms i and j, r0i j is the reference
bond length and kbi j is the force constant. The bond angle stretching term is
Vangles = ∑
angles
1
2
kθi jk
(
θi jk−θ 0i jk
)2
. (4.10)
Here, θi jk is the bond angle defined by atoms i, j and k, θ 0i jk is the reference bond
angle and kθi jk is the related force constant. The dihedral term is
Vdihedral = ∑
dihedrals
kφi jkl
(
1+ cos
(
nφi jkl−φ 0i jkl
))
, (4.11)
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where φi jkl is the angle between ijk and jkl planes and φ 0i jkl is its reference value. The
OPLS force field uses a different form for the dihedral term,
Vdihedral = ∑
dihedrals
1
2
[
C1(1+ cos(φi jkl))+C2(1− cos(2φi jkl)+C3(1+ cos(3φi jkl)
]
.
(4.12)
Additionally, improper dihedrals are used to force planarity of certain groups of
atoms or to preserve chirality of molecules. They are called “improper dihedrals”
because, unlike normal dihedrals, the torsion angle is defined by atoms that are not
necessarily sequentially bonded.
Vimproper = ∑
improper
1
2
ki jkl
(
ξi jkl−ξ 0i jkl
)2
(4.13)
ξi jkl is the angle between ijk and jkl planes like φi jkl . However, unlike in proper
dihedral term, here the atoms i, j, k and l are not necessarily connected via chemical
bonds.
Other forms can also be used to represent the same potential. “Hard” degrees of free-
dom such as bond lengths do not deviate considerably from their minimum values.
So the criterion for such potential functions is that they reproduce their minima very
well. The bonds involving hydrogen atoms are often constrained since the vibrational
energy is higher than the thermal energy2, hν kBT where kBT is thermal energy, h
is Planck’s constant and ν is the vibrational frequency [1].
4.1.4 Force field parameters
In order to completely describe the potential energy surface, constants in Eqns. (4.5)–
(4.8) have to be determined. At present, the main force fields used in biomolecular
simulations are AMBER [140–143], CHARMM [144, 145], OPLS [146–148] and
GROMOS [149]. The functional forms used in all these force fields are similar to
2Bonds involving hydrogen atoms vibrate with frequencies of about 3000–3500 cm−1, so
that hν ≈ 60−−70×10−21 J.
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those described previously. The parameters for equations are determined in a self-
consistent way to reproduce values from experiments or quantum chemistry calcu-
lations. Different force fields follow different philosophies and reproduce different
thermodynamic quantities for parameterizing the constants. Data for small molecules
is used for the parameterization because for large molecules, such as proteins, the
properties of atoms may depend on its environment [150].
Partial charges are assigned to atoms to represent effective atomic charges. The
charges are usually determined by quantum mechanical calculations on the molecule
to be parameterized or on a closely related molecule [151]. These calculations are
typically performed in vacuum and hence the charges often need to be adjusted fur-
ther [138]. In an aqueous environment, the molecular dipoles are larger than in vac-
uum due to mutual polarization [138]. At present, the most commonly used force
fields do not treat polarizability explicitly. Instead the values obtained from quan-
tum chemistry calculations are overestimated to realistically model condensed phase
systems [138].
The Lennard-Jones parameters are typically determined by reproducing condensed
phase experimental quantities such as density, heat of vaporization and heat of sub-
limation [151]. The bond and angle values are determined from crystal structure
values or vibrational spectra [8, 151]. Finally, the torsion terms are parameterized
using quantum mechanical calculations on model compounds or vibrational spectra
of molecules [8]. When a dihedral angle is changed, the energy profile will have
a contribution from the non-bonded interactions between the end atoms (i.e. the 1-
4 non-bonded interaction). Thus, in some force fields, the torsion and non-bonded
terms are coupled and it is not recommended to transfer them separately from one
force field to another one [138]. For proteins the ψ and φ dihedrals of the peptide
backbone are of particular interest since they exist for all the residues and due to their
significance in protein folding. These dihedrals are thus specially treated in some
force fields [138]. The potential energy surface of these dihedrals are calculated for
model systems such as alanine dipeptide using quantum chemistry methods [138].
The molecular mechanics parameters are then calculated by fitting dihedral functions
to these quantum mechanical values.
Now let us discuss the two force fields used in this work, namely OPLS-AA [147]
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and GROMOS 53A6 [149]. Of these two, OPLS is an all atom force field in which
all atoms are explicitly modeled. GROMOS, on the other hand, is a united atom force
field, where non-polar hydrogen atoms bonded to a carbon atom are merged to the
carbon atom. The interaction parameters of the united atom is chosen such that it
effectively represents the group of atoms.
OPLS-AA was parameterized by reproducing structural and thermodynamic quanti-
ties [147]. The bond and angle terms were mostly adopted from the AMBER force
field (in AMBER these terms were determined using crystallographic data and nor-
mal mode frequency data for small molecular fragments [140]). The torsional terms
were determined by fitting to energy values obtained from ab initio calculations. The
non-bonded terms were determined by fitting thermodynamic and structural proper-
ties calculated from Monte Carlo simulations to experimental data. The thermody-
namic properties used for fitting were heat of vaporization, density and free energy
of hydration.
In GROMOS force field the covalent bonded terms were obtained from crystal struc-
tures of small molecules and the corresponding force constants from infrared spec-
troscopic data of small molecules in the gas phase [150]. The dihedral parameters
were obtained by fitting functions to torsional energy profile obtained from quan-
tum mechanical calculations. The first estimates of partial charges were obtained
from quantum mechanical electron density values. Then these values were further
optimized along with LJ parameters. For this step, experimental data for heats of
vaporization, densities of liquids and free energies of solvation of small molecules
in polar (water) and nonpolar (cyclohexane) solvents were used for fitting. Relative
free energy of solvation between polar and nonpolar solutions is important for pro-
tein folding. For 20 amino acids the Gibbs free energies of solvation were calculated
with the GROMOS 53A6 force field [150]. They were found to be very close to the
experimental values, with average deviation smaller than thermal energy.
4.1.5 Numerical methods and practical issues
To get an atomistic trajectory, Hamilton’s equations of motion (4.2) and (4.3) have to
be solved numerically using an integrator. An integrator such as the leapfrog integra-
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tor [152] calculates the position and velocities of atoms at a later time step from their
values at the current (or earlier) time step, using the forces at the current time, F(t):
v
(
t +
∆t
2
)
= v
(
t− ∆t
2
)
+
F(t)∆t
m
(4.14)
r(t +∆t) = r(t)+v
(
t +
∆t
2
)
∆t (4.15)
An assumption made here is that forces do not change noticeably during the small
time step ∆t. Leapfrog algorithm is time-reversible and it conserves energy.
Since computational speed is an issue, it is desirable to use as large time step as possi-
ble. But using a large time step can lead to instabilities [133]. Bonds between atoms,
which have high frequency and low amplitude, are the limiting factor for the integra-
tion time step. To avoid this, such bonds are replaced by constraints using algorithms
such as SHAKE and LINCS. SHAKE [153] is an iterative algorithm which sets the
correct bond lengths sequentially and it is numerically stable. But since bonds are
coupled to one another, SHAKE has the drawback that a solution may not be reached
within a fixed number of iterations. LINCS [154] solves constraint equations non-
iteratively in two steps. It is more stable and up to 4 times faster than SHAKE [154].
Periodic boundary conditions
As will be discussed in Section 4.1.6, the maximum size of a system that can be
simulated using MD is greatly limited. As a result, a large number of the simulated
atoms are at the boundary of any system, unlike in reality. Since the behavior of atoms
at the boundaries is different from those in the bulk, the finite size of the system can
cause artifacts. To reduce these effects, MD simulations are generally performed
with periodic boundary conditions (Fig. 4.2) [133]. Simulations are performed in a
space-filling cell which is surrounded by its own translated images. For calculating
short range interactions between atoms, a minimum image convention is followed:
For calculating the short-range forces, only the distance between an atom and the
nearest image of its interaction partner is considered.
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Figure 4.2. In a periodic boundary condition the simulated system is repeated in a periodic fashion to
reduce finite size effects.
Calculation of electrostatic interactions can be problematic with periodic boundary
conditions. Coulomb interaction is a long range interaction and hence its integral
over all spaces diverges. Thus, special techniques have to be used to calculate elec-
trostatic terms. The Ewald summation method was introduced by Paul Ewald for
calculating the electrostatic energy of ionic crystals. It decomposes the interactions
into short-range and long-range ones and calculates them in real space and the Fourier
space, respectively [155, 156]. The advantage of the method is that the summation
converges rapidly. Ewald summation method scales as N2.
In the reaction field method [157], electrostatic interactions between atoms within
a certain cutoff distance are calculated explicitly. Beyond the cutoff distance, the
medium is treated as a continuum with a dielectric constant εm. This reduces the
number of calculations that need to be performed.
In the particle mesh Ewald (PME) summation method [155], the charges are assigned
to a grid using interpolation. The calculation is done in the Fourier space and forces
are assigned back on to the atoms. The method scales as N log(N) [155] and is
significantly faster than the ordinary Ewald summation.
Temperature and pressure coupling
Solution to Hamilton’s equations (4.2) and (4.3) generate microcanonical ensembles
(constant number of particles, volume and energy or constant NV E). Since experi-
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mental measurements are typically made at constant temperature and constant pres-
sure conditions, preferable ensembles for calculations in simulations are the isother-
mal (NV T ) or isothermal-isobaric (N pT ) ensembles [133].
In the Berendsen temperature coupling scheme [158], the system temperature is
brought to the target temperature T0 by changing the current temperature T at a rate
dT
dt
=
(T −T0)
τ
. (4.16)
The temperature change has an exponential dependance on the constant τ , whose
value dictates how fast the system is brought back to T0. Berendsen coupling, how-
ever, suppresses kinetic energy fluctuations and does not produce a canonical ensem-
ble [159]. So it can not be used for computing quantities. But it rapidly brings the
system to the target temperature and hence is often used for equilibrating the system
before the production run. The stochastic velocity rescaling thermostat by Bussi et
al. [159] generates the canonical ensemble and such thermostats are preferable for
calculation of quantities. The velocities are rescaled to enforce the correct value of
kinetic energy,
dK = (K0−K)dtτ +2
√
KK0
N f
dW√
τ
, (4.17)
where K and K0 are the current and the target kinetic energies, respectively. N f is
the number of degrees of freedom and τ is the coupling constant. dW is a Wiener
process [160] which ensures proper kinetic energy fluctuations. Nosé-Hoover ther-
mostat [161, 162] also generates a canonical ensemble. However, in this approach
the relaxation is oscillatory and hence it takes longer time scales to bring the system
to equilibrium.
The principles behind pressure coupling schemes are similar to those of the tem-
perature coupling schemes, but changes are applied to the pressure tensor P instead
of temperature. In the Berendsen scheme [158], the pressure is maintained at the
preferred value by changing the volume of the simulation box (and coordinates of
atoms accordingly). But again, it does not produce the correct fluctuations and hence
should only be used for equilibration purposes. For production runs, methods such
51
Computational methods
as the Parrinello-Rahman barostat [163, 164] are used.
Dealing with charges
Electrostatic monopole-monopole interactions are long-range and decreases only as
the inverse first power of the distance between the monopoles. If periodic boundary
conditions are applied to a simulation box with a non-zero net charge, its energy will
diverge. Thus, with periodic boundary conditions, the total charge of the box should
be made zero. The molecule that one wants to simulate may have a non-zero net
charge. In this case, counterions are added such that the total charge of the simulated
system is zero.
The ionic concentration inside a cell is different from the surrounding fluid. The
typical concentration of ions inside cells is about 150 mM [165]. So for more realistic
simulations, in addition to the counterions, more ions are added such that the system
has an ion concentration of 100–150 mM. Na+/K+ and Cl− are most commonly
found cations and anions in cells [165] and hence are usually used in simulations.
4.1.6 Some of the challenges
There are many challenges facing the MD simulation community. One of the major
challenges faced by MD, like many other computational methods, is its inadequate
predictive power. MD should be able to accurately compute quantities that are ex-
perimentally measurable. This remains as a challenge especially in macromolecular
simulation even after its four decades of existence [166]. This is partly because the
potential functions representing inter-atomic interactions are sometimes not satisfac-
tory. Another reason for the low predictive power of MD is that it is computationally
very expensive. Consequently, the size of the system and length of simulation time
are limited to a couple of millions of atoms3 and/or a few μs. This finite size and
length may result in insufficient sampling, which will affect the quality of “measure-
ments” in MD simulations. Another disadvantage of MD is the limited transferability
of force field parameters across different types of molecules [167], which limits its
applicability.
3Compare it with 1014 which is the approximate number of atoms in an ordinary human cell.
But vast majority of it is atoms in water molecules.
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Despite these disadvantages, the use of MD has increased rapidly in the past. Almost
all the major force fields used in biomolecular simulations are constantly developed,
making the description of atomic interactions more and more satisfactory [166, 167].
Efficient simulation methods and algorithms are also developed. Replica exchange
molecular dynamics [168], for example, enhances the sampling by simulating many
copies of a system at different temperatures and then swapping the copies at regular
intervals. This helps the samples to overcome barriers in the potential energy sur-
face. Coarse graining is another method developed to speed up the simulations [169].
When a group of atoms is coarse-grained, it is represented by a single interaction
bead. This reduces the number of interactions to be calculated in each MD step. It
also makes the potential energy surface smoother allowing larger time steps. Thus a
speed up factor of 1000 or more can be achieved by coarse graining [170]. Further,
increase in computing power and massive parallel computing techniques have greatly
extended the upper limit of simulation scales in the past two decades [166]. Thus up-
per limit of the length of trajectories generated in MD is also constantly increasing.
As a result of all these developments, MD is becoming a tool for making accurate
predictions [171].
4.2 Molecular Docking
Molecular docking is a method to study the association of two molecules. It predicts
the binding modes and binding energies of one molecule with another one [172, 173].
Docking calculations are much faster than MD and less computationally demand-
ing. But compared to MD, docking is less accurate and its scope is limited. It is
not intended for calculating thermodynamic quantities or simulating dynamics of
molecules. Docking is used in drug design to get binding “scores” for many po-
tential drug molecules on a target protein [173]. The calculations are based either on
the surface complementarity between the two molecules or on molecular mechanics
based potential energy calculations [173].
Molecular docking is typically used to study the binding of small ligand molecules
on larger target proteins, but it is also used to study protein-protein interactions
[172, 174]. In docking simulations, a search algorithm generates a large number
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of conformations for the complex and then energy functions are used to estimate the
binding energy of each conformation. From the generated conformations and their
binding energies, predictions of the complex structure are made. It should be noted
that the goal of docking algorithms is to make a quick prediction, not to calculate
the binding energies accurately. In the most simple case, both the ligand and target
molecules are regarded as rigid bodies and only six degrees of freedom (three trans-
lational and three rotational degrees of freedom of the small molecule) are changed
to generate conformations. But small ligands are, in most cases, highly flexible and
hence are modeled as flexible molecules, treating the protein as a rigid molecule
[172]. In more complex cases, both the ligand and target molecules are modeled as
flexible. Often only the side chains of the binding site residues of the protein are
modeled as flexible [172].
Figure 4.3. A small ligand molecule (GTP) is docked onto a target protein to find out the possible bind-
ing modes and estimate the binding energies. The figure was created using the molecular
graphics software VMD [25].
4.2.1 Method
The search algorithms used in docking can be divided into three classes: system-
atic, stochastic and deterministic [173, 175]. In the first category, all the degrees of
freedom are explored in a systematic way. Systematic algorithms may become cum-
bersome if the number of degrees of freedom is large. In deterministic methods (e.g.
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MD simulation), the initial state determines the conformations that are subsequently
generated. Deterministic methods have the disadvantage that if the complex reaches a
local minimum on the energy surface, it may get trapped there and fail to continue the
search [175]. In stochastic algorithms, the conformations are generated by making
stochastic or random changes to the molecules. Since convergence is not guaranteed
in stochastic methods, multiple copies of the simulations are performed [175].
In this work, a stochastic algorithm called Lamarckian genetic algorithm [176] was
used for docking simulations. It is called a genetic algorithm because it resembles
natural evolution. In this method, a population of potential solutions (in our case
molecular conformations), which represent a population of phenotypes or individu-
als, is produced. Individuals are then mutated and a new generation is produced by
crossover of individuals. In the mutation, small changes such as a change in a dihe-
dral angle, are made to the conformation of individuals. To produce an individual of
the next generation, parts of different individuals of the current generation are com-
bined (crossover). A fitness function (described in Section 4.2.2) is used to evaluate
the individuals and a certain number of the fittest individuals are allowed to evolve
further in each generation. The search is ended when a certain number of generations
are produced or when a satisfactory solution is reached.
4.2.2 Energy function
The docking simulations described in this Dissertation were performed using the
AutoDock docking software version 4.2 [177]. The force field used in AutoDock
for the prediction of free energy is semi-empirical and has been parameterized using
a large library of protein-inhibitor complexes with known structures and inhibition
constants. The binding energy can be written as [178]
∆G = ∆Ulig +∆Uprot +∆Uprot−lig +∆Uconf. (4.18)
Here the ∆’s indicate that the terms are the difference in the energies between the
bound and unbound states. The first two terms on the right-hand side represent the
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intramolecular energy difference for the ligand and protein, respectively. If the pro-
tein or ligand is regarded as a rigid body, the corresponding term is zero. The third
term represents the ligand-protein intermolecular energy difference and the last term
corresponds to the entropy loss upon binding. Uprot−lig is calculated using a pair-wise
potential which has four terms representing van der Waals, hydrogen bond, electro-
static and solvation energy contributions [178]:
Uprot−lig = Wvdw∑
i j
(
Ai j
r12i j
− Bi j
r6i j
)
+Whbond∑
i j
E(t)
(
Ci j
r12i j
− Di j
r10i j
)
+Welec∑
i j
qiq j
εi jri j
+Wsolv∑
i j
(SiVj +S jVi)e
(−r2i j
2σ2
)
. (4.19)
Here Wvdw, Whbond , Welec and Wsolv are scaling factors which are parameterized by
reproducing the known inhibition constants of a large library of protein-ligand com-
plexes. The first term is the Lennard-Jones potential, the constants A and B were
taken from the AMBER force field [179]. E(t) in the second term is to make the hy-
drogen bond term directional. It is determined by finding the probability distribution
of hydrogen bond angles from crystalline structures and then making a fit to the cor-
responding energy function [178, 180]. The parameters C and D are chosen for each
type of hydrogen bond, such that the location and depth of the potential are repro-
duced. Atoms are assigned with Gasteiger partial charges [181] and the contribution
is calculated using Coulomb’s law in the third term. εi j is a distance-dependent di-
electric term. The last term is the desolvation term which estimates the energy cost
of desolvating from water. V is the volume of atoms surrounding a given atom and S
is a desolvation term which estimates the cost of burying atoms during the complex
formation from a fully hydrated state.
The entropy term in Eq. (4.18) has the most simple form and is directly proportional
to the number of rotatable bonds, Ntors,
∆Uconf =WconfNtors. (4.20)
The parameter Wconf is calibrated along with the other W terms of Eq. (4.19).
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4.2.3 Energy calculation
The molecular energy is rapidly calculated by using a grid-based method [182]. In
this approach, prior to the docking calculations, a grid is embedded in the protein.
Ligand atoms are placed at grid points and the interaction energy experienced at each
grid point is calculated. During the actual docking calculations, the interaction energy
of a ligand atom at any location is calculated from its values at grid points around that
location by using trilinear interpolation.
In the grid based approach, as one would expect, the accuracy of calculation depends
on the size of the gird — as grid size increases, accuracy decreases. Similarly, the
speed of the calculation increases with an increase in the grid size. Instead of the
grid based approach, a particle-based method like that used in MD is also possible
and would be more robust. But compared to grid based methods, a particle-based
method is significantly slower. Further, in docking simulations the goal is to make
quick predictions and extremely accurate energy values are often not needed. Hence
particle-based methods are usually not necessary.
4.3 Simulation details
4.3.1 Force fields and parameters
The OPLS-AA force field [146, 147] was used in all studies except in the tubulin-
FUOH study. This choice of was based on the performance of the force fields and also
some practical issues. In the earlier versions of the simulation package used (GRO-
MACS, before version 4.5) GROMOS and OPLS-AA force fields were included, but
not other prominent biomolecular force fields such as AMBER or CHARMM. Be-
tween the two available ones, OPLS-AA performs better. GROMOS, for example,
favors β -sheet structures compared to other secondary structures [183]. OPLS-AA,
on the other hand, has issues in reaching the folded state from an unfolded state,
but once in a folded state, it preserves the protein structure very well [183]. Hence,
OPLS-AA was used whenever it was possible. For tubulin-FUOH simulations, due to
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the absence of appropriate parameters for GTP and GDP molecules in the OPLS-AA
force field, the GROMOS 53A6 force field [149] was employed.
For proteins, the existing parameters in the respective force fields were used. The
parameters for nanoparticles and GTP and GDP molecules were determined as de-
scribed in the following. In conjunction with the GROMOS force field, the parame-
ter choices made for FUOH molecules were as described in [109]. For non-bonded
terms, bare carbon atom (type C) and default hydroxyl group parameters of 53A6
force field were used. Typical hydroxyl group partial charges of 53A6 force field
were assigned to atoms belonging to the –C–OH groups. However, partial charges of
the carbon atoms were reduced to 0.2188e from 0.266e to ensure charge-neutrality
of the molecule. For all the other carbon atoms of the C60 core, the partial charges
were set to zero. The parameters for GTP and GDP were obtained by combining
the guanine parameters for the base and ATP molecule parameters for the rest of the
molecules. Both of these parameter sets are available in GROMOS force field. The
charge states of GTP and GDP were -4e and -3e, respectively. The partial charges on
GTP and GDP atoms were also obtained from GROMOS force field. However, the
terminal hydrogen atom was removed and the resulting charge was distributed on the
oxygen atoms connected to the γ phosphate moiety [109].
In simulations employing the OPLS-AA force field, the bonded parameters for fullerene-
based nanoparticles were adapted from the OPLS-AA force field. The Lennard-
Jones parameters for carbon atoms belonging to the C60 core of the nanoparticle
were adapted from Girifalco [184]. The partial charges of carbon atoms belonging
to the C60 core were set to zero unless they were connected to any of the functional
groups (hydroxyl group in FUOH, and malonic acid group in fullerene-trimalonic
acid derivative). The partial charges for hydroxyl groups of FUOH were also ob-
tained from the OPLS-AA force field. For charge neutrality of the molecules, slight
modifications were made to the partial charge values of carbon atoms connected to
the functional groups. For TMA, the partial charges for these carbon atoms were
assigned by fitting point charges to a quantum mechanically determined electrostatic
potential at the B3LYP/6-31G* level of the theory [185].
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4.3.2 Practical implementation
The simulations were performed using the GROMACS simulation package [149].
Version 4.0.4 was employed for the simulation of taq DNA polymerase, and version
4.5 for tubulin simulations. Version 4.5.4 was used for all other simulations.
In all cases, the protein, protein-nanoparticle complex or the nanoparticle cluster was
placed at the center of a simulation box whose edges were at least 0.9 nm from the so-
lute. The box was then filled with TIP4P [186] (with OPLS-AA) or SPC [187] (with
GROMOS) water molecules. Na+ and Cl− ions were added such that the system was
charge neutral and had an ion concentration of 100 mM (In the case of tubulin, the
ion concentration was 150 mM). However, in the case of the taq DNA polymerase
simulations, ions were added only to make the system charge-neutral. Between each
of the steps described above, the systems were energy minimized using the steepest
descent algorithm implemented in GROMACS.
Each simulation was started with a 50 ps NV T equilibration simulation followed by
a 100 ps N pT simulation. During these runs, the positions of heavy atoms were
restrained. The temperature and pressure were maintained at their targeted values
using the velocity rescaling algorithm by Bussi et. al. [159] and Berendsen coupling
scheme [158], respectively. For production runs, the velocity rescaling algorithm
[159] and Parrinello-Rahman barostat [163] were used for temperature and pressure
coupling, respectively. In all cases, the solute and solvent molecules were coupled to
separate thermostats.
In both equilibration and production runs, a simulation time step of 2 fs was used.
The bonds were restrained using the LINCS algorithm [154]. The non-bonded in-
teractions were calculated using a twin range cut-off scheme (cut-off distances of
0.9 nm and 1.4 nm). Electrostatic interactions were handled using the PME method
[155, 156] with a cut-off of 0.9 nm. OPLS force field represents the folded states
of proteins better when combined with PME compared to OPLS with straight cut-
off [183]. Further, PME is a very fast and efficient method as described in 4.1.5.
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4.3.3 Docking
The docking calculations were performed using the AutoDock automatic docking
software version 4.2 [176]. The default AutoDock force field [182] was used for both
protein and the nanoparticles. This force field is based on the AMBER force field as
described in Section 4.2.
In all docking simulations, the conformation searching was carried out using a Lamar-
ckian genetic algorithm [176]. The number of evaluations was fixed to 2.5× 107.
Since there was no previous knowledge of possible binding sites on any of the pro-
teins, a blind docking was performed, allowing the algorithm to search all over the
protein surface. The proteins were treated as rigid with no flexible backbone or side
chains. The C60 core of the fullerene derivatives was also treated as rigid, but the
bonds of the functional groups and those connecting the functional groups to C60
core carbons were modeled as flexible.
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This chapter discusses the results from the molecular docking and molecular dynam-
ics simulations. In the first two sections, the cluster properties of fullerene-based
nanoparticles and their effect on the secondary structures are described. In Section
5.3, the mechanism of inhibition of taq DNA polymerase activity by fullerene deriva-
tives is studied. In Section 5.4, the inhibition of tubulin self-assembly by fullerol is
studied. Finally, in Section 5.5, the effect of nanoparticles on ubiquitin is described.
The simulation details including the force fields and parameters used are described
in the previous chapter (Section 4.3).
5.1 Cluster properties
In this section the properties of small clusters of fullerene, fullerol and fullerene tri-
malonic acid are described. The systems simulated were (a) a single nanoparticle in
water, (b) a cluster of 13 FUL molecules in an icosahedron configuration, and (c) 13
nanoparticles randomly placed in a box. The simulations were performed at 298 K.
However, for studying the effect of temperature, the set c simulations were also car-
ried out at a higher temperature (350 K). Six independent simulations were performed
for each set, each simulation lasting 100 ns (except the first set of simulations which
were only 5 ns long). In the following, first the results from simulations at 298 K are
described which are then followed by the results from simulations at 350 K.
(a) A single nanoparticle in water
Description. A single nanoparticle was simulated in a box of water for the purpose
of comparison. The temperature was kept at 298 K. The simulations were 5 ns long.
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Results. The solvent accessible surface areas (SASAs) of nanoparticles were calcu-
lated. FUL is hydrophobic and the average surface area was 5.20 nm2. FUOH and
TMA have hydrophilic surface modifications. The total SASA of FUOH was 6.50
nm2 of which 1.60 nm2 and 4.90 nm2 were hydrophobic and hydrophilic, respec-
tively. TMA had a total area of 7.13 nm2 of which 3.58 nm2 was hydrophobic and
3.55 nm2 hydrophilic. The FUOH molecule formed on average of about 34 hydrogen
bonds with water molecules (see Table 5.2).
(b) 13 FUL molecules in an icosahedron configuration
Description. Fullerenes form fcc crystals with a lattice constant of 1.417 nm as men-
tioned in Chapter 3. However, in vacuum, small number of fullerenes form stable
icosahedrons of 13 or 55 molecules [87]. To test stability of such clusters in water, a
13 FUL icosahedron structure was simulated in a box of water. Six simulations, each
lasting 100 ns, were carried out. The temperature was set at 298 K. The results from
these simulations are also important for the other systems described in the following
sections. Icosahedron structure (Fig. 5.1) can be imagined of consisting of two pen-
tagons of fullerenes (green and black) with a central fullerene (orange) and two caps
(bright orange).
Results. The icosahedron structure remained very stable with no fullerenes dissoci-
ating in any of the simulations at any moment. The rms deviations of atomic coordi-
nates were, however, rather large (about 0.5 nm). This is because the fullerenes, while
maintaining the icosahedron configuration, were free to rotate about their centers of
mass. The SASA per fullerene was 2.57 nm2 in the icosahedron structure, which is
half the value of an isolated FUL molecule. It should be noted that this number can
be smaller for larger clusters with more fullerenes buried inside them. Hence this
number itself is not very useful for describing the effect of clustering. However, it
is still meaningful to compare this number for fullerene and its derivatives with dif-
ferent surface modifications. The radius of gyration of the icosahedron structure was
1.01 nm (standard deviation was smaller than 10−2 nm).
(c) Unstructured cluster of 13 molecules
Description. 13 FUL, FUOH or TMA molecules were placed randomly in a box of
water. Six independent simulations were carried out at 298 K, each lasting 100 ns.
62
Results
Figure 5.1. Fullerenes form icosahedral structures of 13 or 55 molecules. Here a 13 molecule icosa-
hedral structure is shown. It can be imagine to consist of two pentagons (brown and dark
green), one central molecule (orange) and two caps (bright orange).
The structures formed by different derivatives and their properties were studied.
Results. In all simulations, fullerene derivatives came close to each other and formed
aggregates. However, the nature and stability of the aggregates formed were different
for different derivatives. A typical structure formed by FUL molecules is shown in
Fig. 5.2 and structures formed by FUOH and TMA at the end of six independent 100
ns simulations are shown in Fig. 5.3.
In all simulations, FUL molecules formed icosahedron-like structures with one or
more FUL molecules at non-ideal locations. The reason for FULs to bind at non-ideal
locations was that there are many different ways of arranging 13 FUL molecules to
make an icosahedron structure. Different FUL molecules thus try to make it in dif-
ferent ways and this causes them to reach a deadlock. Since these non-ideal locations
are local potential energy minima, FUL molecules do not easily rearrange themselves
to make a more complete icosahedron. However, in one of the simulations, FUL
molecules were seen rearranging themselves, forming a more complete icosahedron.
FUOH and TMA did not form icosahedron-like structures in any of the simulations.
This was because they are not spherically symmetric like FUL molecules. FUOH
and TMA molecules rather formed unstructured aggregates. TMA aggregates, unlike
FUOH clusters, were very dynamic with their shapes and sizes changing over time.
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Figure 5.2. Typical structures formed by FUL molecules after 100 ns simulation (right) starting from
a randomly arranged structure (left). The structure formed is icosahedron-like with (in this
case) two cyan FUL molecules at “wrong” locations.
These two molecules lack rotational symmetry that FUL molecules have, and hence
they were not seen rotating about their own centers of mass. This is because, in
a bound state, a molecule requires to have rotational symmetry to be able to rotate
freely about its center of mass.
The rms deviation of coordinates was calculated with respect to the structure at 100
ns. Choosing the last frame as reference structure was useful in distinguishing stable
and unstable structures. For a stable cluster, the structure formed at the last time step
and at a previous time would be very close to each other while for an unstable struc-
ture, they would be different. Hence, the rmsd values for the first case will be smaller
compared to the second case. If the initial structure was used as the reference struc-
ture for rmsd calculations, both types of systems would produce large rmsd values
making it impossible to distinguish stable and unstable structures.
For the FUL system the rmsd value was constant at about 0.5 nm (Fig. 5.4) because
FUL molecules were free to rotate in the icosahedron-like structure. This value, as ex-
pected, was the same as the rmsd value of FUL molecules when the simulations were
started by placing FUL molecules in an icosahedron structure (Section 5.1). TMA
showed large rms fluctuations because TMA aggregates were very loosely formed
and TMA molecules often disassociated from the cluster, occasionally forming more
than one cluster. The stabilities of FUOH aggregates were somewhere between those
of FUL and TMA. They had the smallest rmsd values because the structures were
more stable than TMA, and they do not have the rotational degree of freedom like
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(a) FUOH
(b) TMA
Figure 5.3. Structures formed by FUOH (above) and TMA (below) molecules at the end of six 100 ns
simulations. Unlike FUL, these clusters were dynamic and lacked specific structures. The
size and shape of the clusters changed with time.
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SASA per molecule (nm2)
Hydrophobic Hydrophilic Total
Single molecule
FUL 5.20 0.00 5.20
FUOH 1.60 4.90 6.50
TMA 3.58 3.55 7.13
13 icosahedron (298 K)
FUL 2.57 0.00 2.57
13 random (298 K)
FUL 2.73 0.00 2.73
FUOH 0.97 2.87 3.84
TMA 2.79 3.00 5.79
13 random (350 K)
FUL 2.72 0.00 2.72
FUOH 0.92 2.76 3.68
TMA 2.62 2.51 5.21
Table 5.1. Solvent accessible surface areas per molecule for different systems.
FUOH-FUOH FUOH-Water Total
1 FUOH (298 K) 34.3 34.3
13 FUOH (298 K) 2.5 24.3 26.9
13 FUOH (350 K) 2.7 21.2 23.9
Table 5.2. Hydrogen bonds formed by FUOH molecules with themselves and with water molecules.
FUL molecules.
The average radii of gyration of the clusters were 1.09±0.08 nm, 1.28±0.20 nm and
1.62±0.20 nm for FUL, FUOH and TMA, respectively. TMA clusters had large ef-
fective radii of gyration, once again because of the loosely formed aggregates. TMA
clusters also showed larger SASA compared to FUOH and FUL clusters. FUOH
molecules formed a small number of hydrogen bonds with each other, but the num-
ber of hydrogen bonds formed with water molecules was reduced from 34.3 (for a
single FUOH molecule in water) to 24.3 (see Table 5.2).
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Figure 5.4. Root mean square deviation of atom coordinates from their final values at 298 K and 350
K. At 298 K the TMA structures were loosely formed which caused large fluctuations in
rmsd. In comparison, at t 350 K, the clusters were more closely packed.
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(d) Unstructured cluster of 13 molecules at 350 K
Description. The effect of temperature on cluster properties was studied by simulat-
ing the nanoparticles at a higher temperature. The simulated system was similar to
the previous one, but the temperature was set at 350 K instead of 298 K.
Results. One would expect that the nanoparticles would aggregate less closely to
each other at a higher temperature. However, on the contrary, the nanoparticles were
more closely bound to each other at 350 K in comparison to simulations at 298 K.
All calculated parameters showed this tendency for all the three nanoparticle types.
Temperature had the greatest impact on TMA cluster behavior whereas the effect
was very small for FUL. The radius of gyration values were reduced to 1.08±0.11
nm, 1.21±0.03 nm and 1.34±0.02 nm for FUL, FUOH and TMA at 350 K from
1.09±0.20 nm, 1.27±0.08 nm and 1.62±0.20 nm at 298 K. The rmsd values were also
significantly smaller for TMA at 350 compared to 298 K values (Fig. 5.4), indicating
the clusters were more stable at 350 K. Similarly, a small reduction in SASA was
also observed (see Table 5.1).
Two complementing factors contribute to this temperature effect. The first one is that
at higher temperature the dynamics are faster and the nanoparticles more effectively
cross the barriers of the potential energy surface. Thus, the equilibrium structure
is more easily reached. The second factor is based on the entropy cost of water
molecules around the nanoparticle. When nanoparticles are placed in water, the water
molecules around it can not rotate as freely as water molecules in the bulk. This
causes them some entropy loss. When two or more nanoparticles come close to
each other the total interfacial area between nanoparticles and water decreases and
hence water molecules gain some of the lost entropic energy. This mechanism is
the driving force behind self-assembly of many biomolecules such as lipids [188]. At
higher temperature the entropy of water molecules is higher and so is the entropy loss
due to nanoparticles. Thus, at higher temperature the entropic energy gain of water
molecules up on nanoparticle aggregation is also higher (than at lower temperature),
making the aggregation more favorable. A similar mechanism is responsible for the
cold denaturation of proteins — for maintaining the protein structure, temperature
has to be higher than a certain value [189, 190].
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Peptide Sequence
1ses DREVQELKKRLQEVQ
1fkx EEEKKELLERLYREY
5tim PQQAQEAHALIRSWV
1trr EEWLRFVDLLKNAYQ
3aaq AAQAAAAQAAAAQAA
Table 5.3. The peptides simulated and their amino acid sequences.
5.2 Effect on secondary structure
The effect of fullerene nanoparticles on the α-helix propensities of small peptides was
studied. To this end, a few peptides which were expected to form α-helical structures
were simulated with and without FUOH and TMA. Each peptide was 15 residues
long, and the amino acid sequences were obtained from the I-sites library of proteins
[191]. These sequences have strong secondary structure correlations in the protein
structures available in the Protein Data Bank. The amino acid sequences used are
listed in Table 5.3. The starting helical structures were made by hand with molecular
visualization program PyMOL [192], using its Build tool. The C- and N- termini
of the peptides were modified by adding acetyl and amide groups, respectively. Five
FUOH or TMA nanoparticles were placed around the peptide in complex simulations.
The simulations were performed at 298 K and 1 bar. Eight independent simulations
were carried out for each peptide/peptide-nanoparticle system. Each simulation was
25 ns long, providing a cumulative 200 ns long trajectory for each set.
Results. The number of residues involved in the α-helix formation was calculated
for each simulation. The α-helix forming propensities of the peptides in the absence
of nanoparticles varied. The peptide 3aaq had the lowest number of helical residues
whereas 1fkx had the largest. The average number of helical residues for these pep-
tides were 2.6±1.0 and 8.0±0.4, respectively. For the other three peptides, the helix
forming propensities were in between these values (see Table 5.3).
In simulations with nanoparticles, they were seen binding to the peptides. In the pres-
ence of nanoparticles, no effect was observed for the peptides with high helix form-
ing propensities. For these peptides, changes in the average number of helix forming
residues were within the margins of error. However, for the two less structured pep-
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Figure 5.5. The average helicity of the peptide residues. The averages are taken over the last 10 ns of
the simulations.
Peptide Number of residues
No nanoparticle FUOH TMA
3aaq 2.6±1.0 5.0±1.0 6.2±1.2
5tim 4.2±1.1 6.8±0.6 7.7±0.5
1trr 5.7±0.6 5.7±0.7 7.1±0.9
1ses 6.6±0.4 6.1±0.8 5.9±1.1
1fkx 8.0±0.4 7.4±0.7 8.1±0.7
Table 5.4. The average number of residues forming helices for different peptides. The averages were
calculated over the last 10 ns of the simulations.
70
Results
tides (3aaq and 5tim) a significant increase in the helical propensities were observed
upon nanoparticle binding. For 3aaq, the average number of helical residues were
5.0±1.0 and 6.2±1.2 with FUOH and TMA, respectively. For 5tim, the values were
6.8±0.6 and 7.7±0.5 in the presence of FUOH and TMA, respectively. The residue-
wise helicities of the peptides are plotted in Fig. 5.5. For both these peptides, the
prominent binding areas of nanoparticles were near the residues 5–12 which showed
highest increase in helicity (Fig. 5.5). An analysis of rmsf values of protein residues
showed a decrease in amino acid fluctuations upon nanoparticle binding. These find-
ings indicate that the increase in helicity is induced by nanoparticle binding. How-
ever, further study is underway to assert this.
Discussion. The work presented here is very brief and requires further studies to
understand the bigger picture. Future work directions include extending the present
simulations up to 100 ns and studying the effects on β-sheet peptides or small proteins
with β-sheet structures.
As described in Section 3.4, a general tendency for the helical content to decrease in
the presence of fullerene-based nanoparticles has been reported in many experimental
studies. In this study no such increase in the helical content was observed for any
peptides. But on the the contrary, an increase in the helical content was observed for
some peptides. Although these results are contradicting, increase in helical content
induced by nanoparticles other than fullerene-based ones has been reported in the
literature [193, 194].
The peptides simulated here are amphiphilic in nature. The stabilization of the helical
structures by the nanoparticles was likely due to the hydrophobic interaction between
the two. The hydrophobic areas of a protein are usually buried inside in its folded
structure. So the binding of nanoparticles to these areas may look unlikely. However,
it may still be important for proteins that follow diffusion collision model [195], that
is, proteins in which secondary structures are formed first before they fold into a
tertiary structure.
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5.3 Taq polymerase-fullerene derivative interaction
In this section simulation studies of taq DNA polymerase (taq pol) with two fullerene
derivatives are described. Motivation for this study was described in Section 3.4.
Both docking and molecular dynamics (MD) approaches were used. Docking was
used to find the most likely binding sites of fullerene derivatives on the protein. MD
simulations of the most favorably docked structures and other systems were carried
out to understand the mechanism by which fullerene derivatives affect the functioning
of taq pol. Simulations were performed using only the Klentaq fragment [196] of taq
pol. For brevity, in the following ’taq pol’ is used to refer to the Klentaq fragment of
the protein.
5.3.1 Docking
Description. Two fullerene derivatives — fullerol and fullerene trimalonic acid —
were docked onto both the open and closed structures of taq pol. The closed structure
was in the DNA-bound form whereas no DNA molecule was included in the open
structure. Both structures were obtained from the Protein Data Bank (PDB codes:
1TAQ [15] for the open and 3KTQ [12] for the closed structure). The 5’ nuclease do-
main was cleaved from the 1TAQ structure by hand to get the Klentaq fragment. The
nuclease domain was not included in the original 3KTQ structure. Water and other
small molecules present in the PDB structure were removed. A hundred independent
docking simulations were performed with 10 repeated trials in each simulation, mak-
ing the total number of docked structures 1000 each for open and closed structures.
For each protein-fullerene derivative combination, the root mean square deviations
(rmsds) between the docked structures were calculated. Structures with mutual rmsds
below 0.8 nm were grouped into clusters. Each cluster represents a binding site of
the fullerene derivative on the protein. Typical values used for the rmsd cut-off are
in the range 0.05–0.2 nm for the docking of small molecules. But owing to their
spherical symmetry of the C60 core, fullerene derivatives are able to bind the same
site in different modes by rotating about their center of mass. The docked structures
were clustered using different rmsd cut-off values, and the conformations within and
across clusters were visualized using AutoDockTools [177]. Based on this trial and
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error method, 0.8 nm was found to be the appropriate value which separates confor-
mations corresponding to different binding sites without splitting the conformations
corresponding to the same binding site into two or more clusters. From these bind-
ing sites, the most important sites were identified based on three criteria: (a) binding
energy, (b) frequency of finding the site in repeated docking trials and (c) importance
of the site in the functioning of taq pol.
Figure 5.6. Binding sites of FUOH (blue C60 core) and TMA (green) on taq DNA polymerase in its
open state, as predicted by the docking calculations.
Results and discussion. The important binding sites of the fullerene derivatives on
taq pol are shown in Figs. 5.6 and 5.7. Their binding energies and contributions to
total numbers of docked structures are shown in Table 5.5. In the open form of taq
pol, FUOH had three important binding sites. Site 1 was located in the posterior side
of the protein (with respect to the DNA binding region), site 2 was a pocket in the
fingers subdomain and site 3 in the palm subdomain, near the active site of taq pol.
In the closed state, FUOH was seen to bind sites 1 and 2, and a new site formed by
reorientation of the O-helix, site 6. Site 3 was not a binding site in the closed form
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Figure 5.7. Binding sites of FUOH (blue C60 core) and TMA (green) on taq DNA polymerase in its
closed state based on the docking calculations. The bound DNA molecule is shown in light
blue.
because it is located in the same region where DNA binds to taq pol.
TMA bound to sites 1 and 2 in the open structure, but site 3 was not an important one.
Two new sites, 4 and 5 were also favorable binding sites for TMA. When TMA was
bound these two sites, it bridged the fingers and thumb subdomain (see Fig. 5.6). In
the closed structure docking simulations, favorable sites for TMA were sites 1 and 2,
and two new sites, 7 and 8. Sites 7 and 8 are located at the anterior and the posterior
sides of the fingers subdomain, respectively.
The only site which was observed in both the open and closed structures and for both
fullerene derivatives was site 2. Site 1 was a favorable site for all cases except for
TMA in the open form of the protein. Site 3 was in the DNA binding region. Hence,
it was not a possible site when DNA is bound to the protein in the closed structure.
Since the thumb subdomain is flexible, sites 4 and 5 are transient ones. Sites 6 and 8
are formed only when taq pol is in its closed form.
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Site Eb(kJ/mol) Conf.(%) Open/closed state MD
FUOH, open state
1 23.97 11.0 Both •
2 19.67 55.8 Both •
3 16.40 7.6 Both •
FUOH, closed state
1 21.09 10.5 Both
2 23.68 58.0 Both •
6 5.82 3.6 Closed •
TMA, open state
2 38.83 8.0 Both •
4 48.12 38.3 Open
5 35.94 37.2 Open
TMA, closed state
1 27.45 9.6 Both
2 31.34 43.2 Both •
7 27.07 29.3 Both
8 26.99 7.1 Closed
Table 5.5. Major binding sites of FUOH and TMA on the open and closed structures of the taq pol with
their binding energies Eb and percentages out of all the docked configurations. The table
also shows whether the binding site in question was found for the open, closed or both states
of the protein, and whether the fullerene derivative-binding site pair was included in the MD
simulation studies (•). The binding sites are shown in Figs. 5.6 and 5.7.
5.3.2 Molecular Dynamics
By using docking simulations the possible binding sites of the fullerene derivatives
on taq DNA polymerase were found. To gain a more detailed understanding of the
mechanism by which fullerene derivatives affect the structure and dynamics of taq
pol, a molecular dynamics (MD) protocol was used. The simulation sets used were
the following: In the APO set, the protein was simulated without any fullerene deriva-
tives. In the SxF (or SxT) set, one FUOH (TMA) molecule was placed at site ’x’
predicted by docking calculations. In R10F (R10T), taq pol was simulated with 10
FUOH (TMA) molecules at random locations around it.
The protein structures were obtained from the Protein Data Bank (PDB codes: 1TAQ
for open structure and 3KTQ for closed structure) and were prepared as described in
the previous section. The simulations were performed at 298 K and 1 bar. The poly-
merase chain reaction involves repeated heating and cooling of the reaction solution
[197, 198]. To study the effects of temperature, a few simulations were performed
at 333 K (simulation codes marked with an asterisk sign). During the polymerase
reaction, taq pol switches between its closed and open configurations. Hence a few
simulations of the closed structure (codes marked with a superscript C) were also
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Code System # Time (ns)
Open state (1TAQ), T = 298 K
APO Protein only 4 200, 3×50
S1F 1 FUOH at site 1 3 3×50
S2F 1 FUOH at site 2 3 3×50
S3F 1 FUOH at site 3 3 3×50
S2T 1 TMA at site 2 2 100, 50
R10F 10 FUOH randomly placed 6 2×100, 4×50
R10T 10 TMA randomly placed 6 2×100, 4×50
Open state (1TAQ), T = 333 K
APO* Protein only 4 2×100, 2×50
R10F* 10 FUOH randomly placed 3 100, 2×50
R10T* 10 TMA randomly placed 3 100, 2×50
Closed state (3KTQ), T = 298 K
APOc Protein only 2 2×200
S2Fc 1 FUOH at site 2 2 100, 50
S6Fc 1 FUOH at site 6 2 100, 50
S2Tc 1 TMA at site 2 2 100, 50
Table 5.6. Summary of the systems studied in the MD simulations. The table lists the codes assigned
to each specific simulation set-ups, explanation of the set-up, number of independent simu-
lations, and the simulation times of the independent runs.
performed. The typical lengths of simulations were 50-200 ns. Table 5.6 lists all the
simulation sets along with their number of independent runs and lengths.
(a) Protein without any nanoparticles (APO)
Description. For comparison with the other simulations the protein was first simu-
lated in its open state without any nanoparticles. Four independent simulations with
a cumulative length of 250 ns were performed at 298 K.
Results. Visual examination revealed that the protein was in general very stable
with no significant change in the structure. However, an exception to this was the
tip of thumb subdomain which was flexible and mobile. This is not surprising be-
cause when DNA binds the protein this region undergoes a structural change. In this
structural transition, the tip of the thumb makes a contact with the DNA and “holds”
it. The root mean square fluctuations (rmsf) of residues, root mean square deviation
(rmsd) of the Cα atoms from the crystal structure (Fig. 5.8), and DSSP analysis [199]
of the secondary structure of the protein were conducted. The rmsf of the residues at
tip of the thumb were higher than for the rest, as one would expect. No noticeable
changes in the secondary structure was observed (see Fig. 5.11).
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Figure 5.8. Root mean square deviation (rmsd) and root mean square fluctuation (rmsf) plots for taq
pol without any nanoparticles. The rmsd is calculated using only the Cα atom coordinates.
The crystal structure (1TAQ) was used for reference. The rmsf calculations were performed
for each residue. Different colors represents plots for independent runs.
(b) One nanoparticle at a binding site (SxF/SxT)
Description. In this set of simulations, the protein was simulated with a single
fullerene derivative placed at one of the binding sites predicted by docking. However,
not all favorably docked structures were simulated. Three independent simulations
were carried out for each nanoparticle-binding site combination.
Figure 5.9. The number of hydrogen bonds that nanoparticles make at sites 1, 2 and 3 as a function of
time
Results. In all simulations, the nanoparticles remained at their respective binding
sites during the entire simulation. This indicated that the binding sites predicted by
docking simulations were indeed very favorable sites. However, in one exceptional
case a fullerol was seen to move away from site 3 and bind to an adjacent site (called
3A in the following) 1 nm away from it. The fullerol remained at this new site for the
rest of the simulation. A new set of docking studies performed at site 3A predicted a
binding strength of 4.8 kJ/mol. This value is much smaller than the binding strength
at site 3 (16.4 kJ/mol). When bound at the binding sites, fullerene derivatives made
contact with many protein residues. Table 5.7 lists the residues that were within 0.5
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nm of the fullerene derivatives at each binding sites studied.
The fullerene derivatives also formed a number of hydrogen bonds with the protein
(see Fig. 5.9). On average, FUOH formed 3.6, 8.7 and 4.7 hydrogen bonds with
the protein at sites 1, 2 and 3, respectively. At site 2 TMA formed an average of
5.7 hydrogen bonds. The average lifetime of the hydrogen bonds were 17.8±0.9 ps,
32.4±5.1 ps and 22.2±4.0 ps for FUOH at sites 1, 2 and 3, and 72.9±4.5 ps for TMA at
site 2. It is worth noting that in their small clusters FUOH and TMA formed smaller
numbers of hydrogen bonds with each other (see Section 5.1). Table 5.8 lists the
average number of hydrogen bonds the individual protein residues formed with the
fullerene derivatives.
Figure 5.10. Tertiary structure change observed in S2F and S2T simulations. The tip of the thumb
subdomain (yellow) moved towards and bound to the fingers subdomain.
In S2F and S2T simulations, a significant change to the tertiary structure was ob-
served. The tip of the thumb subdomain moved towards the fullerene derivative
which was bound at site 2 in the fingers subdomain (see Fig. 5.10). By doing so,
the thumb residues Lys505 or Lys508 made contact with the fullerene derivative. For
the rest of the simulation, the tip of the thumb subdomain remained bound to fingers
domain.
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Site-fullerene Residues
1-FUOH Met317, Ala360, Leu361, Arg362, Glu363, Gly364, Leu365,
His443, Ala446, Thr447, Thr557, Arg559, His561, Glu773, Arg778
2-FUOH Lys505, Lys508, Gly672, Gln 690, Ile693, Glu694, Phe697,
Arg704, Ile707, Glu708, Leu711, Arg715, Arg741, Glu742,
Glu745, Arg746, Phe749
3/3A-FUOH Thr569, Ala570, Thr571, Arg573, Cysh575, Asn580, Gln582,
Asn583, Ile584, Pro585, Val586, Phe667, Leu670, Tyr671, Arg746,
Met747, Asn750, Gln754, His784
2-TMA Lys505, Gly672, Met673, Ser674, Gln690, Ile693, Glu694, Phe697,
Arg704, Ile707, Glu708, Leu711, Arg715, Lys738, Arg741,
Glu742, Glu745, Arg746, Phe749
Table 5.7. Taq DNA polymerase residues in contact with the fullerene derivatives at binding sites 1, 2,
and 3. The residues forming hydrogen bonds with DNA at the active site are highlighted in
boldface.
Site 1 - FUOH Site 2 - FUOH Site 2 - TMA Site 3/3A - FUOH
Residue #HB Residue #HB Residue #HB Residue #HB Residue #HB
Leu 361 0.994 Lys 505 0.017 Lys 505 0.165 Thr 385 0.121 Gln 582 1.160
Gly 364* 0.037 Lys 508 0.140 Ser 674 0.025 Asn 565 0.106 Asn 583 0.213
Leu 365 0.023 Gly 672* 0.278 Ala 675* 0.159 Ala 568* 0.206 Arg 728 0.024
His 443 0.198 Gln 690 0.562 Gln 690 0.152 Thr 569 0.197 Asn 750 0.449
Ala 446* 0.510 Glu 694 0.168 Arg 704 1.451 Ala 570* 0.285 Gln 754 0.319
Thr 447 0.931 Arg 704 0.695 Arg 715 0.826 Thr 571 0.767 His 784 0.200
Glu 773 0.496 Glu 708 1.458 Lys 738 0.791 Arg 573 0.266
Arg 778 0.409 Arg 715 0.147 Arg 741 0.674 Cys 576 0.154
Arg 741 0.079 Arg 746 0.964 Asp 578 0.089
Glu 742 1.235 Asn 580 0.090
Glu 745 2.016
Arg 746 1.095
Table 5.8. Average numbers of hydrogen bonds (#HB) formed by FUOH and TMA with the residues at
the binding sites 1, 2 and 3. A hydrogen bond with the backbone is designated by an asterisk
after the name of the residue.
(c) Many nanoparticles around protein (R10F/R10T)
Description. In the R10F and R10T simulations, ten FUOH or TMA molecules were
placed at random positions around the protein. Six independent runs were simulated
with a cumulative time of 400 ns for R10F and R10T each. The initial positions of
the fullerene derivatives were changed in each simulation for better sampling. The
simulations were performed at 298 K on the open structure.
Results. The fullerene derivatives immediately moved towards the protein surface
and remained bound to the surface for the rest of the simulation. There were no partic-
ularly favorable sites for fullerene derivatives. However, TMA showed a tendency to
bind to positively charged residues because of its large negative charge (-6e). FUOH,
on the other hand, had a tendency to bind to polar or charged residues. Both fullerene
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Figure 5.11. DSSP analysis showed no significant change to the secondary structure of taq pol in the
presence of nanoparticles. In this figure, the secondary structures formed by taq pol
residues as a function of time for a simulation without any nanoparticles (left) and one
simulation with 10 FUOH nanoparticles (right) are shown.
derivatives formed hydrogen bonds with the protein residues as expect. Each FUOH
molecule formed on average of 3.5 hydrogen bonds while TMA made an average of
2.6 bonds. These numbers are smaller than the numbers of hydrogen bonds formed at
the binding sites predicted by docking. This also indicates that the sites predicted by
docking simulations were very favorable binding sites for the fullerene derivatives.
The hydrogen bond lifetimes were 24.2±3.2 ps and 49.0±9.9 ps for FUOH and TMA,
respectively.
Further, in some simulations fullerene derivatives were bound the protein at the bind-
ing sites predicted by docking simulations. However, they were not seen to bind to
all the bindings sites predicted by docking calculations. This is likely due to the sam-
pling limitations of MD. The protein is rather large and the longest simulations were
limited to 100 ns due to computational cost. The sampling was however enhanced to
a certain degree by using 10 fullerene derivatives in a single simulation. It is worth
mentioning at this point that the binding sites are not always well defined in MD as
in the static docking calculations. This is because in MD the protein is flexible and
consequently changes to binding sites may occur. This is especially true for the tip
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Figure 5.12. The number of residues of the protein forming secondary structures in the presence and in
the absence of fullerene derivatives.
of the thumb subdomain.
The secondary structure of the protein was analyzed using DSSP1 [199]. Fullerene
derivatives did not seem to make any significant change to the secondary structure.
In Fig. 5.11, the secondary structures formed by each residue is plotted as a function
of time for both protein-alone and protein with 10 FUOH simulations. In Fig. 5.12,
the number of residues that form secondary structures is plotted as a function of time
for the protein with and without FUOH and TMA.
Binding of the fullerene derivatives at certain locations caused significant changes to
the protein tertiary structure. In some simulations, the fullerene derivative was seen
to bind to two α-helices (H-helix, residues 453–477, and I-helix, residues 527–552,
see Fig. 2.6) of the thumb subdomain. This caused these helices to bend, as depicted
in Fig. 5.13. This tertiary structure change was not observed in any of the simulations
where the nanoparticles did not bind to the H and I helices.
Another kind of tertiary structure change was seen in the tip of the thumb subdo-
main. Similar to observations in the S2F and S2T simulations, in some simulations
this region moved towards the fingers subdomain. In such occasions, the fullerene
derivatives were seen to bridge the fingers and thumb subdomains by binding to both
of them.
1DSSP is an algorithm to assign secondary structures to a protein structure. The algorithm is
based on the intra-backbone hydrogen bonding patterns and energies.
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Figure 5.13. In simulations in which FUOH bound the H and I helices of the protein, a bending of
these helices. In other simulations in which no FUOH molecules bound to these helices,
no such structural changes were observed. The crystal structure is shown in green and
simulated structure in orange.
We defined two groups of residues in the fingers and thumb subdomains and cal-
culated the distance between their centers of mass for the APO, R10F and R10T
simulations. The chosen residues were 496-510 in the thumb and 673-690 and 732-
742 in the fingers subdomains. The average value of this distance in the last 10 ns of
simulations was 2.6±0.3 nm for APO, 2.2±0.4 nm for R10F and 1.5±0.2 nm for R10T
simulations. The error estimates were made by finding the standard deviation of val-
ues between independent runs. In one R10F simulation none of the FUOH molecules
bound to the tip of the thumb. If this simulation was excluded from the analysis, the
average distance was 2.0±0.2 nm.
(d) Many nanoparticles, at T=333K (R10F*/R10T*)
Description. 10 fullerene derivatives of same type (FUOH or TMA) were placed
around the protein, and three independent runs of FUOH and TMA simulations were
carried out. The cumulative time of the simulations was 200 ns for FUOH and TMA
each. The simulations were carried out at a temperature of 333 K. The motivation for
using a higher temperature simulations was the fact that the polymerase chain reac-
tion is usually set up at a temperature significantly higher than the room temperature.
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Results. The protein showed no significant change in structure or stability. The rmsd
values of the Cα atom coordinates were 0.40±0.04 nm, 0.52±0.12 nm and 0.37±0.01
nm for protein alone, protein-FUOH and protein-TMA simulations, respectively. The
average number of hydrogen bonds FUOH and TMA formed with the protein at 333
K were 3.7 and 2.7 respectively. These are smaller than the average values at 298
K. The lifetimes of hydrogen bonds were 20.3±0.2 ps and 40.5±1.8 ps for FUOH
and TMA, respectively. The distance between the groups of residues described in
the previous section were 2.3±0.3 nm, 1.9±0.2 nm and 1.4±0.1 nm for protein alone,
protein-FUOH and protein-TMA simulations, respectively.
(e) Closed structure (APOc/SxFc/SxTc)
Description. The closed structure of the protein was simulated without the bound
DNA molecule. The motivation for conducting this simulation was to check whether
the closed-to-open transition would be affected by fullerene derivative binding. The
systems simulated were taq pol without any fullerene derivatives, taq pol with FUOH
or TMA at site 2 and taq pol with FUOH at site 6. The temperature was set at 298 K,
and two independent runs of simulations were performed in each case.
Results. In the simulations without any fullerene derivatives (APOc), we expected
that the protein would go from the closed to open state. However, in neither one of
the two 200 ns simulations such a transition was observed. The reason for this could
be that the closed structure is a local minimum even in the absence of DNA. In that
case more independent of simulations would be required to see the closed-to-open
transition and to compare it with the protein-fullerene derivative complex cases.
In one of the simulations with FUOH at site 2 (S2Fc), the protein made a transition
from the closed to open state. This indicates that FUOH binding does not prevent the
closed-to-open transition. However, no such transition was observed in any of the
other protein-fullerene derivative complex simulations.
5.3.3 Possible inhibition mechanisms
In the following possible inhibition mechanisms of taq pol by FUOH and TMA are
considered one by one. The reasons for accepting or rejecting them are discussed.
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Finally some experimental methods for testing the proposed inhibition mechanisms
are discussed.
Direct binding at the active site. The active site of the protein consists of three
acidic residues. TMA is highly negatively charged and so it is not expected to bind to
the negatively charged active site. However, FUOH is polar and it can, in principle,
bind to the active site making hydrogen bonds with the acidic side chains. However,
in neither docking nor in MD, the fullerene derivatives were seen to bind to the active
site of the protein. The reason for this is that both FUOH and TMA are too large to fit
into the active site which is located in a cleft in the palm subdomain. So it is unlikely
that the fullerene derivatives inhibit taq pol by binding directly at the active site.
Binding at sites 3 and 3A. FUOH was seen to bind to sites 3 and 3A of the protein.
These two sites are located in a region in the palm subdomain where DNA binds to
the protein. FUOH made contact with many protein residues when bound to these
sites. At site 3 FUOH made hydrogen bonds with residues Ala570, Thr571, Gln582,
Asn583, Asn750 and Gln754. Similarly, at site 3A, FUOH made hydrogen bonds
with Thr385, Ala568, Cys576, Cys577, Asp578 and Asn580. When a DNA molecule
binds the protein, it makes contact with many residues including Ala568, Cys577
(Ser577), Asn580, Asn583, Asn750, and Gln754 [200]. Thus, FUOH binding at sites
3/3A would directly affect the DNA binding and hence the activity of the protein.
However, TMA did not bind to sites 3 or 3A in any of the simulations and cannot
inhibit the protein with this mechanism. Further, for FUOH such inhibition would be
competitive. Since FUOH and DNA cannot bind to the protein simultaneously, they
would compete for the binding site. Then, if the concentration of DNA (or FUOH) is
increased, the inhibition effects should decrease (increase). But this is not the case.
In PCR experiments when the concentration of DNA was increased, no significant
reversal of inhibition was observed [121]. Thus we conclude that although binding
of FUOH at sites 3/3A can contribute to the inhibition, it cannot be the only (or major)
inhibition mechanism.
Tertiary structure changes due to binding. In some of the simulations with many
FUOH/TMA particles around the protein (R10F/R10T simulations), the protein ter-
tiary structure changed significantly. The thumb subdomain has two long α-helices,
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the H-helix (residues 453–477) and the I-helix (residues 527–552), see Fig. 2.6. In
some simulations, binding of FUOH at these two helices caused them to bend as
shown in Fig. 5.13. Such bending was not observed in any of the simulations without
FUOH or in simulations where the fullerene derivatives did not bind these helices.
Interestingly, the I-helix is involved in DNA binding and makes a number of contacts
with a taq pol-bound DNA.
There was also a second kind of tertiary structure change observed in simulations with
fullerene derivatives. In a few simulations with FUOH or TMA bound at site 2, the
tip of the thumb subdomain moved towards the fingers domain. Two lysine residues
of the thumb strongly bound to the fullerene derivatives preventing the thumb from
going back to its original position. Similar thumb-to-fingers movements were also
observed in simulations with many fullerene derivatives placed around the protein.
In these cases, the fullerene derivatives acted like a bridge by binding both to the tip
of the thumb and fingers subdomains.
Changes in the tertiary structure described above would affect the DNA binding in
a non-competitive fashion. Although at higher DNA concentrations the availability
of DNA would increase, the taq pol would not be able to bind them. This means
that if the concentration of DNA was increased, the inhibition would not be reversed.
On the other hand, if the concentration of taq pol was increased keeping the same
concentration of the fullerene derivatives, there would be more unaffected protein
molecules. Thus an increase in enzyme activity could be expected with an increase
in the concentration of the protein. This is indeed exactly what was observed in
experiments.
Point mutation studies to check the predictions. In point mutation studies one or
more specific amino acids of a protein are replaced with different amino acids. This
allows one to investigate the effect of that particular amino acid in the functioning or
disfunctioning of the protein. In our case, two of the inhibition mechanism described
above are based on the binding of fullerene derivatives to two thumb helices, tip of
the thumb and at site 2. The binding to the two helices was not very specific to any
residues. Further, the tip of the thumb and one of the helices (I-helix) have very
conserved residues which are involved in DNA binding. Mutation studies on these
residues are thus very difficult.
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Many residues at site 2, on the other hand, are not conserved and hence would be
suitable for mutation studies. It is also important to note that FUOH and TMA bind to
different residues at site 2 (see Table 5.7). Residues that dominantly bound to FUOH
were Glu708, Glu742, Glu745 and Arg746. Among these only Arg746 was seen to
bind TMA. Arg746 is also absolutely conserved in the polymerase family. Glu708
and Glu742 are not conserved, whereas Glu745 is somewhat conserved. Thus the
residues Glu708 and Glu742 would be optimal candidates for mutation studies.
5.4 Tubulin-fullerene derivative interaction
5.4.1 Docking
Description. FUOH molecule was docked onto a tubulin dimer to find the most
probable binding sites. The crystal structure of the tubulin dimer with bound GDP
and GTP was obtained from Protein Data Bank (PDB ID: 1JFF [26]). The missing
residues of this structure were added using the program MODELLER 9v7 [201, 202].
Docking simulations were performed using the AutoDock 4.2 software [177] with its
default parameters [182]. The C60 core of FUOH was treated as rigid and the C-O
bonds connecting the hydroxyl groups to the C60 core were modeled as flexible. 50
docking simulations were performed with 10 trials in each simulation. The number
of evaluations was set at 2.5×107.
In reality the proteins are flexible molecules and can adjust the relative positions
of atoms and residues. Thus it is desirable to perform docking on conformations
generated e.g. by MD simulations. However, since tubulin is a dimer molecule, in
MD simulations the two monomers can change their structures independently. Even
small such changes would make it difficult to simultaneously fit both monomer con-
formations (generated by MD) to their crystal structures. We found that this causes a
practical problem in docking while defining the binding sites (which is based on rms
deviations of the docked FUOH structures). As a trade-off between this practical dif-
ficulty and desirability to use multiple protein conformations, we used two structures
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Figure 5.14. Eight binding sites of FUOH molecule on a tubulin dimer identified by docking simula-
tions.
in docking simulations–the crystal structure and a conformation tubulin formed after
10 ns of MD simulations.
Results. As in the case of taq pol, 1000 docked conformations (500 for each protein
conformation) were grouped into different clusters based on the mutual rmsds. Eight
binding sites were identified as the important ones based on the binding energy, pop-
ulation of the clusters and the importance of the sites. The binding sites identified
are shown in Fig. 5.14, and the binding energies and populations of these clusters are
summarized in Table 5.9.
It is worth mentioning at this point that in a microtubule, the neighboring tubulins
are connected either laterally (on the left/right sides in Fig. 2.8) or longitudinally (on
top/bottom sides in the same plane in Fig. 2.8). Thus, most of the predicted binding
sites are located at either interdimer or intradimer interfaces: sites 1, 7 and 8 are at
the intradimer interface, whereas all other sites are located at the interdimer interface.
5.4.2 Molecular dynamics
The binding of FUOH could affect the secondary, tertiary or quaternary structure of
the protein. To examine this, two sets of MD simulations (tubulin dimers with or
without FUOH molecules) were carried out.
87
Results
Lowest
binding
Site energy Population Residues within 0.7 nm of FUOH
kJ/mol
1 27.2 85 Asn102, Glu411, His406, Arg158, Asp163, Asn197,
Thr198, Asp199, Val257, Phe262, Arg264, His266
2 17.2 60 Pro89, Asp90, Asn91, Phe92, Val93, Phe94, Leu114,
Ser117, Asp120, Val121, Lys124, Arg79
3 16.7 91 Phe49, Asn50, Phe53, Arg123, Asp127, Cys129,
Leu130, Phe135, Tyr161, Lys163, Lys164
4 15.5 57 Lys336, Thr337, Lys338, Arg339, Thr340,
Gln342, Phe343, Asp345
5 13.8 97 Thr257, Asn258, Val260, Pro261, Tyr262,
Trp346, Cys347, Pro348, Thr349
6 11.3 86 Val177, Ser178, Thr180, Val181, Val182,
Glu183, Pro184, Tyr185, Arg390, Glu393,
Gln394, Phe395, Phe404, Lys176
7 16.7 33 Gln176, Arg390, His393, Lys394, Leu397, Leu333,
Gln336, Asn337, Glu345, Trp346,
Ile347, Pro348, Asn349, Asn350
8 12.6 45 Tyr36, Asp39, Ser40, Asp41, Leu42,
Gln43, Ile358, Pro359, Arg369
Table 5.9. Eight most important binding sites of FUOH on tubulin, the binding energies and populations
(out of the total 1000 conformations) and the protein residues within 0.7 nm of FUOH. The
α subunit residues are shown in normal and the β subunit residues in italic typeface.
The structure of the tubulin dimer was obtained as described previously (Section
5.4.1). In complex set, 10 FUOH molecules were placed at random locations around
the protein. The simulations were carried out at 298 K and 1 bar. Four independent
simulations, each lasting 50 ns were carried out for both sets.
(a) Tubulin without any FUOH molecules
Description. The tubulin dimer was simulated with its bound GTP and GDP molecules.
Four independent simulations, each 50 ns long, were carried out.
Results. The two tubulin monomers remained bound to one another during each of
the 50 ns simulations. Similarly the binding of GTP and GDP to the protein was
also stable. However, there were some changes in the protein secondary structure.
An overall decrease in the total number of residues involved in secondary structures
was observed (see Fig. 5.15). When different types of secondary structures were
examined separately, the number of residues forming α-helices showed a tendency
to decrease while the number of residues forming β-sheets increased. This was not
surprising because the GROMOS force field is known to have certain problems in
preserving the secondary structures. It has a generic tendency to form β-sheets at the
expense of other secondary structures and hence it is a “β-sheet friendly” force field
[183]. The reason for choosing GROMOS force field despite this known problem
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was that, it is the only force field for which the parameters for all the three types of
molecules (protein, GTP/GDP and FUOH) were available. Further, other force fields
also have similar problems in preserving the secondary structures [183].
(b) Tubulin with 10 FUOH molecules
Description. In this set, the tubulin dimer was simulated with ten FUOH molecules
placed randomly around it. Four copies of the simulations were performed, each
lasting 50 ns. For better sampling, the FUOH molecules were placed at different
locations in each simulation.
Results. In all the simulations it was observed that FUOH binds to different sites with
no single preferential binding site. It was also observed in docking simulations that
FUOH has many equally important binding sites. Both these computational results
are consistent with ITC experiments which indicated that FUOH binds at up to 9 sites
[120].
Once bound to the sites, FUOH molecules remained bound there for the rest of the
simulations. This can be seen in Fig. 5.16 in which the minimum distance between
FUOH and tubulin residues is plotted for one simulation. At these sites FUOH
formed a number of hydrogen bonds. On average, each FUOH molecule formed
about six hydrogen bonds at the protein surface (see Fig. 5.16). This number is
higher than the average number of hydrogen bonds FUOH formed with taq pol. The
reason for this could be that tubulin has many flexible loops between secondary struc-
tures which could adjust easily to bind the nanoparticle. Further, when FUOH binds
at the intradimer interface, the contact area with the protein is larger and hence FUOH
makes contact with more residues there.
Experiments indicated a decrease in the total number of α-helical residues and an
increase in the beta sheet residues when FUOH concentration was increased up to
100 mg/L [120]. To check this, the secondary structure of the protein was analyzed
in the presence of FUOH. As in protein-only simulations, there was an overall ten-
dency for a decrease in the number of α-helical residues and an increase in the β-sheet
residues. This change is typical to GROMOS 53A6 force field [183] and was also
observed in the previous set of simulations in which no FUOH molecules were in-
cluded. When the two sets of simulations were compared (Fig. 5.15), the number
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Figure 5.15. Secondary structures formed by tubulin with and without FUOH molecules. There is an
overall β-sheet friendly tendency inherent to the force field. However, if the two sets of
simulations are compared, the number of α-helical residues is slightly smaller and the
number of β-sheet residues is slightly larger for the tubulin-FUOH system.
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Figure 5.16. Top: Tubulin-FUOH minimum distance as a function of time for 10 FUOH molecules
in an MD simulation. The average over 10 molecules is also shown. Bottom: The total
number of hydrogen bonds that 10 FUOH molecules make in each simulation as a function
of time.
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Figure 5.17. A tubulin dimer with its two longitudinal neighbors. The binding sites of FUOH at the
longitudinal interface are also shown. Binding of FUOH at these sites would affect the
dimer-dimer contact and hence the microtubule self-assembly.
of α-helical residues was slightly smaller (1.8 ± 1.1)% and the number of β-sheet
residues was slightly larger (1.9±1.7)% in the presence of FUOH. Although this is
consistent with the experimental observations, the differences are very small. Such
changes in secondary structures of proteins due to nanoparticles have been reported
in many studies [130], but the exact reason is not very well understood.
It was shown that FUOH can bind dNTPs with binding energies greater than 10
kJ/mol [109]. It is thus possible that FUOH molecules bind the GTP/GDP (which
are very similar to dNTPs except for one hydroxyl group) in the E/N sites of tubulin.
If FUOH binds to the E-site, it would affect the GDP/GTP exchange which plays an
important role in the microtubule self-assembly. However, neither in the docking nor
in the MD simulations these sites were found to be favorable sites for FUOH. It is
not surprising that FUOH does not bind to the N-site because it is buried inside in the
dimer. However, the E-site is exposed in the dimer and hence FUOH can bind there.
5.4.3 Possible mechanism
Based on the docking and MD simulation results, the following is a possible mech-
anism by which FUOH may affect the microtubule dynamics. The tubulin dimer
makes a number of contacts with its neighbors when incorporated into a microtubule.
These include longitudinal contacts with neighbors belonging to the same protofila-
ments (α-β interdimer contact) and lateral contacts with neighbors belonging to ad-
jacent protofilaments (α-α and β-β contacts). If FUOH molecules bind to tubulin
at these areas, they could affect the longitudinal and lateral contacts and hence the
microtubule dynamics.
The length distribution and dynamics of microtubules are related to each other as
mentioned in Section 2.4. But, can we say anything about the effects of FUOH on
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Figure 5.18. The interaction between the M-loop of one dimer (blue) and the helices H5 and H12 (pur-
ple) in a neighboring dimer contribute most to the interdimer lateral contacts in zinc sheets
[26]. FUOH was observed to make contacts with these structures in the MD simulations.
microtubule dynamics (or microtubule length distribution) from our studies? The
reason behind such a question is the fact that the structure of the tubulin dimer used
in this study was obtained from X-ray crystallography of zinc-induced sheets [26],
and not from microtubules themselves. In zinc-induced sheets the protofilaments are
arranged in an anti-parallel fashion, unlike in microtubules in which they are parallel
[24]. However, the longitudinal contacts between dimers in zinc sheets are similar
to those in microtubules [26]. In Fig. 5.17, a tubulin dimer with its two longitudinal
neighbors is shown. The binding sites of FUOH at these interfaces are also shown.
Clearly, binding of FUOH at these sites would affect the dimer-dimer interactions
and hence tubulin insertion into microtubules.
How about the lateral contacts? Contacts between the M-loop of one tubulin and H5
and H12 helices of an adjacent tubulin is a major contributor to the lateral interaction
between tubulins in zinc sheets [26]. The M-loop is also involved in the lateral con-
tacts in microtubules [26]. In Fig. 5.18 the binding of FUOH to M-loops and the two
helices (as seen in the MD simulations) is shown. These bindings would obviously
affect the lateral contact between tubulins in a microtubule.
Thus, we showed using our computational methods that multiple FUOH molecules
bind to tubulin dimers forming a number of hydrogen bonds in agreement with indi-
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cations from the ITC measurements. The secondary structure of tubulin is marginally
affected by FUOH binding, in qualitative agreement with the experiments. The in-
hibition of microtubule assembly is likely due to the FUOH binding at lateral and
longitudinal contact areas of tubulin dimers.
5.5 Ubiquitin-nanoparticle interactions
The interaction of fullerene (FUL) and fullerol (FUOH) with ubiquitin is described
in this section. Both docking and molecular dynamics approaches were utilised. The
motivation for this study is described in Section 3.4.
5.5.1 Docking
Description. FUL and FUOH nanoparticles were docked on to a ubiquitin molecule.
The structure of ubiquitin was obtained from Protein Data Bank (PDB ID: 1UBQ
[203]). Fifty docking simulations with 10 trials in each simulation were carried out
for both FUL and FUOH.
Results. The docked conformations were clustered according to their mutual root
mean square deviations. For FUL, only one major binding site was predicted (shown
on the left side in Fig. 5.19). This site is located near the bend formed by residues
Ala46 and Gly47. It has a binding energy of 29.7 kJ/mol and contributed about 90%
to all the docked conformations.
For FUOH, two binding sites were observed (shown on the right side in Fig. 5.19).
First site was same as the FUL binding site. It contributed about 57% of docked con-
formations with an energy of 34.3 kJ/mol. The residue Tyr59 is located in the vicin-
ity of this binding site. According to fluorescence quenching experiments, FUOH
molecules bind to the protein in the proximity of Tyr59 [125]. The second site con-
tributed 34% of the conformations and had a binding energy of 33.9 kJ/mol. This site
is located near the C-terminal tail of the protein. Residues which make contact with
FUOH at this site are the terminal residues 72–76.
94
Results
Figure 5.19. Binding sites of FUL and FUOH on ubiquitin molecule as predicted by docking simula-
tions.
5.5.2 Molecular Dynamics
The systems simulated were (a) one ubiquitin molecule without any nanoparticles, (b)
one ubiquitin with multiple nanoparticles distributed around it, and (c) one ubiquitin
with multiple nanoparticles placed at one side of the protein.
(a) Ubiquitin without any nanoparticles
Description. In this set, the protein was simulated with no nanoparticles. As usual,
this enabled us to compare the effect of nanoparticles on the protein properties. Six
simulations, each lasting 100 ns, were carried out at 298 K.
Results. Ubiquitin is a small but very stable protein. The stability of the protein was
reflected in the MD simulations. Overall, the structure remained unchanged with the
exception of the long tail in the C-terminus which wiggled during the simulation. The
rms deviation from the crystal structure was very small (average about 0.20 ± 0.03
nm) even with the inclusion of the fluctuating C-terminus. No significant change in
the secondary structure was observed in the DSSP analysis (see Fig. 5.22).
(b) Multiple nanoparticles distributed around ubiquitin
Description. Ubiquitin was simulated with multiple nanoparticles distributed around
it. The number of nanoparticles was either 5 or 13, and the nanoparticles were either
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Figure 5.20. Secondary structures formed by ubiquitin residues in one of the simulations. The sec-
ondary structure analysis was performed using the program DSSP [199].
FUL or FUOH molecules. For each set, six independent simulations were performed,
each lasting 100 ns.
Results. As the simulations were started, the nanoparticles were bound to the protein
at various locations. There were two locations where nanoparticles (especially FUL)
preferentially bound. One of these is near the C-terminal tail (upper right side in
Fig. 5.21) and the second one near the turn formed by residues Ala46 and Gly47
(lower left side). In docking studies, these two sites were predicted as binding sites
for FUOH, and one of them (lower left) for FUL. After binding to the protein surface,
the nanoparticles showed a tendency to form aggregates. This tendency was more
apparent for FUOH in comparison to FUL (See Fig. 5.21).
Upon nanoparticle binding, no overall change in the structure of the protein was
observed. The secondary structure was well preserved just like in the protein-only
simulations (see Fig. 5.22). However, the rms deviations of the protein coordinates
was slightly smaller than the corresponding values in the protein-only simulations.
This was likely due to binding of nanoparticles to the long C-terminal tail, which
would reduce its fluctuations. The rms fluctuations of the protein residues were cal-
culated, and the tail residues indeed showed lower fluctuations in the simulations
where nanoparticles were present. The reduction in rms deviation (and rmsf of tail
residues) was larger when 13 nanoparticles were distributed in comparison to the
simulations with 5 nanoparticle. This is expected because with a larger number of
nanoparticles, more nanoparticles bind to the C-terminal tail. The average number
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Figure 5.21. Snapshots of the structures formed by ubiquitin and 13 FUL (top) or 13 FUOH (bottom)
at the end of 100 ns simulations. The structures of the protein from independent simu-
lations are superimposed and the nanoparticles from independent simulations are colored
differently. FUL seemed to have strong preferential locations whereas FUOH showed a
high tendency to cluster on the protein surface.
of residues involved in secondary structures and the average rms deviations are listed
for each set in Table 5.10.
(c) Multiple nanoparticles placed at one side of ubiquitin
Description. The simulations were performed by placing 13 FUL or FUOH nanopar-
ticles at one side of the protein. In this set, the nanoparticles were able to cluster
before binding to the protein. The simulations were carried out to understand how
the clustering of nanoparticles affects the interaction with the protein. For FUL an
additional set of simulation was carried out. Since fullerenes are known to form an
icosahedron structure, 13 FUL molecules were arranged in the respective configura-
tion at the beginning of these simulations. For each set, six 100 ns long independent
simulations were performed.
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Figure 5.22. The average number of ubiquitin residues forming secondary structures in the absence
and in the presence of 13 FUL or 13 FUOH molecules. The nanoparticles, if present,
were distributed around the protein at the beginning of the simulations.
System # Secondary rms System description
structure deviation (nm)
Protein 52.1±0.5 0.20±0.03 Protein without any nanoparticle
Protein-FUL-n13 51.4±1.2 0.15±0.01 13 FUL distributed around the protein
Protein-FUOH-n13 51.3±1.0 0.16±0.02 13 FUOH distributed around the protein
Protein-FUL-n5 52.2±0.9 0.19±0.03 5 FUL distributed around the protein
Protein-FUOH-n5 52.1±0.8 0.17±0.03 5 FUOH distributed around the protein
Protein-FUL-side-n13 52.1±1.0 0.19±0.04 13 FUL placed at one side of the protein
Protein-FUOH-side-n13 52.0±0.5 0.20±0.04 13 FUOH placed at one side of the protein
Protein-FUL-side-icosa 52.5±0.5 0.20±0.02 13 FUL placed in an icosahedron
configuration at one side of the protein
Table 5.10. Average number of ubiquitin residues involved in secondary structures and the rms devia-
tion of the protein coordinates for different systems simulated. The standard deviation of
the run-averages are also shown.
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Figure 5.23. Snapshots of structures formed by ubiquitin and 13 FUL (left) or 13 FUOH (right) at
the end of 100 ns simulations. The nanoparticles were placed together at one side of the
protein (instead of distributing around the protein).
Results. In these simulations, the nanoparticles first formed aggregates before bind-
ing to the protein. The structures formed after 100 ns simulations are shown in Fig.
5.23. The apparent difference with the previous set of simulations was that both FUL
and FUOH tended to remain as aggregate even after binding to the protein. In some
of the simulations, the binding of the nanoparticle aggregate to the protein was min-
imal (see Fig. 5.23). When FULs were simulated in the icosahedron configuration,
the structure remained intact and binding with the protein did not seem to have any
effect. The rms deviation of FUL coordinates was about 0.5 nm. Similar values of
rms deviation were observed for icosahedron structure in water in the absence of any
other molecules (see Section 5.1).
Discussion
We observed that both the nanoparticles studied here bind to the protein in all sets of
simulations. However, the nature of the binding depends on the type of nanoparticle
and how they were distributed at the beginning of the simulation. In general, if the
nanoparticles were distributed around the protein in the beginning, the binding was
more uniform. On the other hand, if they were placed together at one side of the
protein, allowing them to form aggregates before binding to the protein, the nanopar-
ticles formed aggregates which then were bound to the protein. However, the binding
of aggregates was minimal in some simulations. It is possible that the difference be-
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tween the binding modes may be a result of the inadequate sampling time. However,
we saw in Section 5.1 that nanoparticles can aggregate on much shorter time scales.
Thus it is possible that the nature of the nanoparticle cluster can play a significant
role in the interaction with proteins. Many experimental studies have indeed shown
that the interaction between nanoparticles and proteins depends on the size and shape
of the nanoparticles [124].
When nanoparticles bind to the C-terminal tail, the rms fluctuation of tail residues
were reduced. The formation of polyubiquitin is extremely important in the func-
tioningof ubiquitin-proteasome systems. Polyubiquitins are formed by the attach-
ment of the C-terminal residue of one ubiquitin molecule to Lys48 or Lys63 residue
of another (see Section 2.5). Because of the crucial role of the C-terminal residue,
the binding of FUL and FUOH to the C-terminal tail and subsequent reduction in the
flexibility of the tail is likely to have an impact on the ubiquitin-proteasome system.
This can be asserted only after experimental studies.
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6. Conclusions
The theme of this Dissertation is computational modeling of the interaction between
proteins and fullerene-based nanoparticles. The motivation for this study comes from
the growing concerns about biological effects of engineered nanoparticles. Many
experiments have indeed shown that the normal functionalities of proteins were re-
duced as a result of their interaction with nanoparticles. Here, molecular docking
and molecular dynamics simulations were used to understand the mechanisms be-
hind the decreased activities. This combination was very effective to find the binding
sites of nanoparticles on proteins, and the changes in the structure and dynamics of
proteins upon nanoparticle binding. Since the functioning of a protein depends on it
three-dimensional structure, insights into the mechanism of inhibition were obtained.
The study on protein–nanoparticle interactions was augmented by two complemen-
tary studies. The properties of small clusters of fullerene-based nanoparticles, and
the effects of these nanoparticles on α-helical propensities of small peptides were
investigated.
According to this work, two fullerene-based nanoparticles — fullerol and fullerene
trimalonic acid derivative — cause major tertiary structure changes to taq DNA poly-
merase. The inhibition of the activity of taq polymerase upon nanoparticle binding
was attributed to these tertiary structure changes. The results were consistent with
the experimental findings on the differences between the inhibitory activities of two
nanoparticles. In the second study, fullerol was shown to have a tendency to bind
to the M-loop and H5 and H12 helices of the tubulin. The interaction between M-
loop of one tubulin and the H5 and H12 helices of the neighboring tubulin is a major
contributor to the tubulin–tubulin binding energy in microtubules. In the third study
the binding and its effects on ubiquitin were examined. The binding of fullerene
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and fullerol nanoparticles seemed to depend on the nature of the nanoparticle clus-
ter and also on the surface modifications. The flexibility of the C-terminal tail —
which takes part in polyubiquitin formation — was reduced upon nanoparticle bind-
ing, implying potential effects on the protein degradation system. The nature and
stability of nanoparticle clusters were found to depend heavily on the surface moi-
eties of the nanoparticles. The clusters were packed and stable for fullerene which
has a hydrophobic surface. For fullerol and trimalonic acid nanoparticles, which have
hydrophilic surface groups, the clusters were less strongly packed and were dynamic.
Finally, the stabilizing effects of nanoparticles on some small α-helical peptides was
observed.
A common finding from this work is that the binding of the fullerene-based nanopar-
ticles to the proteins studied is not specific. However, there were some locations on
the protein surfaces which were preferential sites for the nanoparticles. Shape com-
plementarity may have a role in this regard. The surface functional groups of the
nanoparticles also had a great impact on binding. This was particularly true if the
surface groups were charged. Changes in the structure and dynamics were able to be
captured within the time scales of the simulations.
For docking simulations the flexibility of a protein can be important in some cases.
In the work presented in this Dissertation the protein side chains at the binding sites
were modeled as flexible. But by doing so, no significant changes were observed in
the binding energies or binding modes. Further, in publication [120], conformations
generated by MD simulations were used to account for the conformational changes
of the protein.
The time scales involving α-helix formation is below hundred nanoseconds whereas
the unfolding kinetics are much faster (less than 15 ns, depending on the length)
[204]. The study on the secondary structures of peptides would still benefit from
extending each simulation up to 100 ns or more. Since different force fields have
tendencies to form particular secondary structures, it will also be important to repeat
the simulations with different force fields in order to make sure that the differences
observed are not due to any force field bias.
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